# EDGAR Filing Document

**Accession Number:** 0000877860
**File Stem:** 0000877860-26-000135
**Filing Date:** 2026-5
**Character Count:** 240950
**Document Hash:** 09c4b0b60b96314bfb7c888b08ba235d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000877860-26-000135.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0000877860-26-000135

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 96

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NATIONAL HEALTH INVESTORS INC
- **CENTRAL INDEX KEY:** 0000877860
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 621470956
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10822
- **FILM NUMBER:** 26937536

**BUSINESS ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129
- **BUSINESS PHONE:** 6158909100

**MAIL ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129

?xml version='1.0' encoding='ASCII'? nhi-20260331

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

WASHINGTON, D.C. 20549

**FORM 10-Q**

---

| | | | | |
|:---|:---|:---|:---|:---|
| (Mark One) | (Mark One) | (Mark One) | (Mark One) | (Mark One) |
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|  | For the quarterly period ended | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|  | For the transition period from | _____________ | to | _____________ |

---

Commission file number 001-10822

**<u>National Health Investors, Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Maryland | Maryland | 62-1470956 |
| (State or other jurisdiction of <br>incorporation or organization) | (State or other jurisdiction of <br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| 222 Robert Rose Drive | 222 Robert Rose Drive |  |
| Murfreesboro | Tennessee | 37129 |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

(615) <u>890-9100</u> <br> (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value per share | NHI | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 29, 2026, the registrant had 48,471,079 shares of common stock outstanding.

------

**NATIONAL HEALTH INVESTORS, INC.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | Page |
| <u>[Part I. Financial Information](#i7be82291d41c4937b5956e6b61736008_10)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Financial Statements](#i7be82291d41c4937b5956e6b61736008_13)</u> | <u>[3](#i7be82291d41c4937b5956e6b61736008_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets](#i7be82291d41c4937b5956e6b61736008_16)</u> | <u>[3](#i7be82291d41c4937b5956e6b61736008_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Income](#i7be82291d41c4937b5956e6b61736008_19)</u> | <u>[4](#i7be82291d41c4937b5956e6b61736008_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows](#i7be82291d41c4937b5956e6b61736008_25)</u> | <u>[5](#i7be82291d41c4937b5956e6b61736008_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Equity](#i7be82291d41c4937b5956e6b61736008_28)</u> | <u>[7](#i7be82291d41c4937b5956e6b61736008_28)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to the Condensed Consolidated Financial Statements](#i7be82291d41c4937b5956e6b61736008_34)</u> | <u>[9](#i7be82291d41c4937b5956e6b61736008_34)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i7be82291d41c4937b5956e6b61736008_82)</u> | <u>[36](#i7be82291d41c4937b5956e6b61736008_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#i7be82291d41c4937b5956e6b61736008_121)</u> | <u>[60](#i7be82291d41c4937b5956e6b61736008_121)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Controls and Procedures](#i7be82291d41c4937b5956e6b61736008_127)</u> | <u>[61](#i7be82291d41c4937b5956e6b61736008_127)</u> |
| <u>[Part II. Other Information](#i7be82291d41c4937b5956e6b61736008_130)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Legal Proceedings](#i7be82291d41c4937b5956e6b61736008_133)</u> | <u>[62](#i7be82291d41c4937b5956e6b61736008_133)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1A. Risk Factors](#i7be82291d41c4937b5956e6b61736008_136)</u> | <u>[62](#i7be82291d41c4937b5956e6b61736008_136)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5. Other Information](#i7be82291d41c4937b5956e6b61736008_139)</u> | <u>[62](#i7be82291d41c4937b5956e6b61736008_139)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6. Exhibits](#i7be82291d41c4937b5956e6b61736008_142)</u> | <u>[63](#i7be82291d41c4937b5956e6b61736008_142)</u> |
| <u>[Signatures](#i7be82291d41c4937b5956e6b61736008_145)</u> | <u>[64](#i7be82291d41c4937b5956e6b61736008_145)</u> |

---

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

*($ in thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
| | March 31,<br>2026 | December 31,<br>2025 |
|  | *(unaudited)* |  |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land | $230816 | $221660 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buildings, building improvements and intangible assets | 3148991 | 3055866 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction in progress | 19309 | 18214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 3399116 | 3295740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Accumulated depreciation and amortization | (843828) | (821982) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties, net | 2555288 | 2473758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage and other notes receivable, net of credit loss reserves of |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$15,341 and $15,397, respectively  | 205949 | 203296 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 24948 | 19624 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rents receivable | 79303 | 78891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale, net | 3562 | 3562 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 20815 | 17756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets<sup>1</sup> | $2889865 | $2796887 |
| Liabilities and Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt, net | $1269668 | $1163814 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 37846 | 43734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends payable | 44610 | 44439 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 5207 | 4996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities<sup>1</sup> | 1357331 | 1256983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitments and contingencies |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redeemable noncontrolling interest | 9922 | 10195 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;National Health Investors, Inc. stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value per share, 100,000,000 shares authorized, |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48,459,369 and 48,302,944 shares, respectively, issued and outstanding | 485 | 483 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital in excess of par value | 1920451 | 1922713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 2787108 | 2747006 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative dividends | (3193269) | (3148659) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total National Health Investors, Inc. stockholders' equity | 1514775 | 1521543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 7837 | 8166 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 1522612 | 1529709 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $2889865 | $2796887 |

---

<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;The condensed consolidated balance sheets included the following amounts related to our consolidated variable interest entities: $501.6 million and $403.4 million of real estate properties, net; $6.9 million and $9.1 million of cash and cash equivalents; $0.4 million and $0.6 million of straight-line rents receivable; $3.6 million and $4.2 million of other assets, net; and $4.5 million and $5.5 million of accounts payable and other liabilities as of March 31, 2026 and December 31, 2025, respectively.

*See the accompanying notes to the condensed consolidated financial statements.*

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

*(unaudited and $ in thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Revenues: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income | $73150 | $68866 |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services | 37060 | 13939 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income | 4920 | 6491 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 115130 | 89296 |
| Expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 23691 | 19157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 15040 | 14337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior housing operating expenses | 28169 | 10853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal expense | 305 | 1426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 215 | 269 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 7851 | 6829 |
| &nbsp;&nbsp;&nbsp; Proxy contest and related expenses |  | 264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes and insurance on leased properties | 2804 | 2887 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty gains, net | (50) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 78025 | 56008 |
| Gains on dispositions of real estate properties, net | 2612 | 114 |
| Gains from equity method investment |  | 415 |
| Other non-operating income | 35 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 39752 | 33817 |
| Add: Net loss attributable to noncontrolling interests | 350 | 348 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to stockholders | 40102 | 34165 |
| Less: Net income allocated to participating securities | (78) | (52) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | $40024 | $34113 |
| Weighted average common shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 48323945 | 45720496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 48547893 | 45878528 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.83 | $0.75 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.82 | $0.74 |

---

*See the accompanying notes to the condensed consolidated financial statements.*

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

*(unaudited and $ in thousands)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $39752 | $33817 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 23691 | 19157 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | 725 | 725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of notes receivable commitment fees and discounts | (65) | (103) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs and discounts | 854 | 978 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 2240 | 2558 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments | (723) | (1410) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest income on mortgage notes receivable | (242) | (243) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan and realty gains, net | (50) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on dispositions of real estate properties, net | (2612) | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment |  | (415) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | (3571) | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | (7081) | (8522) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 522 | 74 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 53440 | 46478 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisitions of real estate properties | (105488) | (74484) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in existing real estate properties and equipment | (2895) | (2183) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from dispositions of real estate properties | 6662 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in mortgage and other notes receivable | (6056) | (19135) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments received on mortgage and other notes receivable | 3891 | 19918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions received from equity method investment |  | 415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (103886) | (75469) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility | 140000 | 261000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of revolving credit facility | (35000) | (145000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of term loans |  | (112) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common shares, net |  | 65483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments of equity issuance costs |  | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions paid to noncontrolling interests | (289) | (311) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (44439) | (41119) |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock incentive awards | (4502) | (128) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 55770 | 139766 |
| Increase in cash, cash equivalents and restricted cash | 5324 | 110775 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 19624 | 26502 |
| Cash, cash equivalents and restricted cash at the end of the period | $24948 | $137277 |

---

*See the accompanying notes to the condensed consolidated financial statements.*

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)** 

*(unaudited and $ in thousands)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Supplemental disclosures of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid | $17525 | $16873 |
| Supplemental disclosures of non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate property acquired to settle mortgage note receivable |  | 8600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right of use assets acquired in exchange for finance lease liabilities | 243 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to real estate property renovations | 799 | (95) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to noncontrolling interest distributions | (37) | (68) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to taxes paid on stock option exercises |  | 8 |

---

*See the accompanying notes to the condensed consolidated financial statements.*

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF EQUITY**

*(unaudited and $ in thousands, except per share amounts)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | | | | | |
| | Shares | Amount | Capital in<br>Excess of<br>Par Value |<br>Retained<br>Earnings |<br>Cumulative<br>Dividends |<br>Noncontrolling<br>Interests |<br>Total<br>Equity |
| Balances at December 31, 2025 | 48302944 | $483 | $1922713 | $2747006 | $(3148659) | $8166 | $1529709 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income, excluding a net loss of $256 attributable  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to redeemable noncontrolling interest |  |  |  | 40102 |  | (94) | 40008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 2240 |  |  |  | 2240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grants of restricted stock awards | 39997 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued due to stock options exercised | 118377 | 2 |  |  |  |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incentive awards | (1949) |  | (4502) |  |  |  | (4502) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $17 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | (235) | (235) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends declared, $0.92 per share |  |  |  |  | (44610) |  | (44610) |
| Balances at March 31, 2026 | 48459369 | $485 | $1920451 | $2787108 | $(3193269) | $7837 | $1522612 |

---

*See the accompanying notes to the condensed consolidated financial statements.*

------

<u>[Table of Content](#i7be82291d41c4937b5956e6b61736008_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF EQUITY**

*(unaudited and $ in thousands, except per share amounts)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | | | | | |
| | Shares | Amount | Capital in<br>Excess of<br>Par Value |<br>Retained<br>Earnings |<br>Cumulative<br>Dividends |<br>Noncontrolling<br>Interests |<br>Total<br>Equity |
| Balances at December 31, 2024 | 45687942 | $457 | $1736831 | $2604829 | $(2975642) | $8912 | $1375387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income, excluding a net loss of $243 attributable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to redeemable noncontrolling interest |  |  |  | 34165 |  | (105) | 34060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common shares, net | 960000 | 10 | 65473 |  |  |  | 65483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issuance costs |  |  | (47) |  |  |  | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 2558 |  |  |  | 2558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grants of restricted stock awards | 29500 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued due to stock options exercised | 16763 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incentive awards | (534) |  | (136) |  |  |  | (136) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $7 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | (236) | (236) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends declared, $0.90 per share |  |  |  |  | (42024) |  | (42024) |
| Balances at March 31, 2025 | 46693671 | $467 | $1804679 | $2638994 | $(3017666) | $8571 | $1435045 |

---

*See the accompanying notes to the condensed consolidated financial statements.*

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

*(unaudited)*

**Note 1. Description of the Business**

National Health Investors, Inc. ("NHI", the "Company", "we", "us" or "our"), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and Senior Housing Operating Portfolio ("SHOP"). Our investments in senior housing communities, also referred to as senior housing properties ("SHO"), include independent living facilities ("ILF"), assisted living facilities ("ALF"), entrance fee communities ("EFC") and senior living campuses ("SLC"). Our investments in medical facilities include skilled nursing facilities ("SNF") and hospitals ("HOSP").

As of March 31, 2026, our Real Estate Investments segment consisted of gross real estate investments of $2.7 billion in 175 properties located in 32 states, excluding one property classified as assets held for sale, and leased pursuant primarily to triple-net leases to 30 tenants. These investments included 109 SHOs, 65 SNFs and one HOSP. Additionally, our investments included $221.3 million in principal amounts of mortgage and other notes receivable, excluding $15.3 million of credit loss reserves.

As of March 31, 2026, our SHOP segment consisted of gross real estate investments of $742.5 million in 35 senior housing communities located in 15 states and comprised of 17 ILFs, 11 SLCs and seven ALFs with a combined total of 3,469 units. We outsource the operations at these properties to third-party managers and pay a management fee for these services. As of March 31, 2026, 16 of our senior housing communities were held in consolidated partnerships in which the noncontrolling common equity interests are owned by affiliates of the respective managers.

References in these condensed consolidated financial statements related to property, bed and unit counts are outside the scope of our independent registered accounting firm's review.

**Note 2. Significant Accounting Policies**

*Basis of Presentation*

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial statements. In our opinion, the condensed consolidated financial statements reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation. Interim results of operations are not necessarily indicative of the results that may be achieved for a full year. The condensed consolidated financial statements and related notes do not include all information and notes required by GAAP for annual reports. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission ("SEC").

*Principles of Consolidation*

Our condensed consolidated financial statements include our wholly owned subsidiaries and partnerships that we control through voting rights or other means. All intercompany transactions and balances are eliminated in consolidation.

If we conclude that we are the primary beneficiary of a variable interest entity ("VIE"), we consolidate the entity. The designation of an entity as a VIE is reassessed upon certain events, including but not limited to (i) a change to the contractual arrangements of the entity or in the ability of a party to exercise its participation or kick-out rights, (ii) a change to the capitalization structure of the entity or (iii) acquisitions or dispositions of interests that constitute a change in control. Reference Note 16 for additional information on our VIEs.

We use the equity method of accounting when we own an interest in an entity over which we can exert significant influence but cannot control the entity's operations. We discontinue the equity method of accounting if our investment in an entity, including our net advances to the entity, is reduced to zero, except in those instances in which we have guaranteed the obligations of the entity or are otherwise committed to provide further financial support to the entity. Reference Note 6 for additional information on our equity method investment.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Reclassifications*

Certain prior year amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform with the current period presentation. These reclassifications occurred in operating cash flows in the condensed consolidated statement of cash flows and within the segment table in Note 15.

*Segments*

We operate our business through two reportable segments, Real Estate Investments and SHOP. In our Real Estate Investments segment, our investments include (i) the ownership of SHOs and medical facilities which we lease to third-party healthcare operators and (ii) financing arrangements with our tenants, operators, or affiliates of our tenants and operators, and other third parties, primarily mortgages, construction loans, mezzanine loans and revolving lines of credit which fund acquisitions, construction projects and working capital needs associated with healthcare properties. In our SHOP segment, we invest in both the operations and real estate of senior housing communities and utilize third-party managers to operate these properties on our behalf.

*Revenue Recognition*

*Rental Income*

We generate rental income from the properties in our Real Estate Investments segment pursuant to leases between us and the tenants who operate these properties. These leases are typically triple-net operating leases with fixed annual escalators. We recognize the contractual amounts of base rental income from a tenant lease using the straight-line method over the initial term of the lease, subject to a collectability assessment. Certain of our leases provide for additional contingent rent based on a percentage of the tenant's revenues in excess of a specified annual or quarterly base amount or other threshold as defined in the lease agreement. We recognize contingent rent as rental income when the actual results reported by the tenant have exceeded the applicable base amount or threshold.

Our leases are primarily triple-net leases in which the tenant pays the related expenses for property taxes and insurance either directly to the third-party vendor or as a reimbursement to us. Upon adoption, we elected the lessor practical expedient within Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 842, Leases ("ASC 842"), which permits us to combine the lease and non-lease components of our tenant leases as the timing and pattern of transfer of the underlying services to the tenant are the same. We determined the lease component is the predominant component within these contracts in accordance with ASC 842 and therefore recognize the revenues from these contracts under ASC 842. As a result, tenant reimbursements of property operating expenses, which may include property taxes and insurance, are recognized as rental income in our condensed consolidated statements of income. The corresponding expenses incurred by us are recognized in taxes and insurance on leased properties in our condensed consolidated statements of income.

At lease inception, we may make certain payments to our tenants that are treated as lease incentives. These amounts are amortized over the respective lease term and recognized as a reduction of rental income in our condensed consolidated statements of income. Certain lease incentives are inducements subject to a contingent event. We recognize contingent lease inducements in the period in which the uncertainty associated with the contingent consideration becomes probable that it will be subsequently resolved and that a significant reversal of amounts recognized in revenues is not likely to occur. We recognize lease incentives in other assets, net, on our condensed consolidated balance sheets.

We assess the collectability of lease payments due from tenants on a regular basis taking into consideration factors such as a change in the tenant's payment history, the current financial condition of the tenant, other new business or market conditions that may affect the tenant's operations and changes in economic conditions in the geographical areas where the tenant operates. In the event that we determine the future collectability of substantially all lease payments of a tenant are no longer probable, we write off the related accounts receivable and straight-line rents receivable in the period in which this determination becomes known as a reduction of rental income and begin recognizing rental income from the tenant on a cash basis. Any recoveries of previously written-off accounts receivable are recognized as rental income in the period payment is received. Reference the "Cash Basis Tenants" section in Note 5.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Resident Fees and Services*

We generate resident fees and services revenues from the senior housing communities in our SHOP segment pursuant to independent agreements for each residential unit at these communities. These revenues include resident room and care charges, community fees and other charges for optional services available to the residents.

Resident fees and services revenues are recognized as services are provided. Resident agreements generally have terms of 30 days to one year and are cancelable by the resident with 30-days notice. We typically bill residents a fixed monthly fee at the beginning of each month for room fees and general care services. Certain of the more individualized need-based and optional services are billed to residents monthly in arrears. Community fees are billed to residents upon move-in and recognized into revenue over periods of less than two years. Upon adoption of ASC 842, we elected the lessor practical expedient which permits us to combine the lease and non-lease components of our resident agreements as the timing and pattern of transfer of the underlying services to the resident are the same. We determined that the non-lease component is the predominant component within these contracts in accordance with ASC 842 and therefore recognize the revenues from these contracts under ASC 606, Revenue Recognition from Contracts with Customers ("ASC 606").

*Interest Income from Mortgage and Other Notes Receivable*

We recognize interest income as earned based on the interest rates and principal amounts outstanding on our mortgage and other notes receivable. Accrued interest on mortgage and other notes receivable is included in other assets, net, on our condensed consolidated balance sheets. We assess the collectability of our mortgage and other notes receivable on a regular basis taking into consideration factors, such as the borrower's timeliness of required payments, the borrower's current financial condition and the borrower's compliance with other covenants and terms of the loan agreement. If we conclude that a loan has become non-performing, we place it on non-accrual status in the period in which it becomes known and probable that the borrower cannot pay the contractual amounts due to us. A non-performing loan is returned to accrual status if the borrower becomes contractually current on payments and management believes all future principal and interest will be received from the borrower in accordance with the terms of the loan agreement. Reference the "Non-Performing Notes" section in Note 4.

*Real Estate Properties*

Our investments in real estate properties are accounted for as asset acquisitions. We allocate the purchase price to the identified tangible and intangible assets based on the relative fair values of the assets as of the acquisition date. The related transaction costs are included in the purchase price allocation. Contingent consideration deemed to be probable at the acquisition date, if any, is also included in the purchase price allocation to the extent that a significant reversal of amounts recognized is not likely to occur and the uncertainty associated with the contingent consideration has been resolved.

We use the straight-line method of depreciation for buildings over their estimated useful lives ranging from 30 years to 40 years and building improvements over their estimated useful lives ranging from five years to 25 years. Repairs and maintenance costs are expensed as incurred. Intangible assets related to the fair values of in-place resident leases are amortized using the straight-line method over the estimated absorption periods.

*Impairment of Long-Lived Assets*

We monitor events and changes in circumstances, including investment operating performance and general market conditions, which could indicate that the carrying amounts of our long-lived assets may not be recoverable. When indicators of potential impairment are present, we assess whether an impairment charge is needed by comparing the future estimated undiscounted cash flows and eventual disposition of the identified asset to its carrying amount. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying value of the identified asset exceeds its estimated fair value. Impairment charges are included in loan and realty losses (gains), net, in our condensed consolidated statements of income.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Assets Held for Sale*

We classify real estate properties as assets held for sale on our condensed consolidated balance sheets when the following conditions are met: (i) management commits to a plan to sell the property; (ii) the property is available for immediate sale in its present condition; (iii) an active program to locate a buyer has been initiated; (iv) the property is being marketed for sale at a price that is reasonable given our estimate of its current market value; (v) a sale is highly probable within one year; and (vi) it is unlikely that the disposal plan will be significantly modified or discontinued.

If a real estate property meets the criteria to be classified as held for sale, we remeasure the asset at the lower of the carrying amount or the estimated fair value less cost to sell and upon reclassification, we no longer depreciate the property. We estimate the fair value of a property using a market approach that takes into consideration any recent binding agreements for sales of similar properties, any recent purchase offers we have received for the property and estimates based on broker quotes and third-party valuations. If a property subsequently no longer meets the criteria to be classified as held for sale, it is reclassified as a held and used asset and remeasured at the lower of the original carrying amount before the asset was classified as held for sale, adjusted for any depreciation expense not recognized while it was classified as held for sale or its fair value.

*Mortgage and Other Notes Receivable*

Mortgage and other notes receivable consist of mortgages, construction loans, mezzanine loans and revolving lines of credit investments with certain of our tenants, operators, or affiliates of our tenants and operators, and other third parties. Mortgage and other notes receivable are recognized on our condensed consolidated balance sheets net of any deferred commitment fees, discounts, premiums and allowances for credit losses. We amortize deferred commitment fees, discounts and premiums over the contractual lives of the loans using the effective interest method. If a loan is repaid prior to its contractual maturity date, we recognize the remaining unamortized balances of any deferred commitment fees, discounts and premiums in the period the loan is repaid.

*Credit Loss Reserves on Mortgage and Other Notes Receivable*

We evaluate the collectability of our mortgage and other notes receivable and establish reserves for expected credit losses at the inception of these investments and subsequently on a quarterly basis at the end of the period. The calculations of our credit loss reserves are based on our estimates of the total future credit losses we expect to incur over the remaining amortization periods of the loans. As a result, we may recognize some credit loss expense prior to the actual events of default. Credit loss expense (benefit) is recognized in loan and realty losses (gains), net, in our condensed consolidated statements of income.

Our models for estimating the future expected credit losses on mortgage and construction loans are calculated on a collective basis for these types of loans. Our models for estimating the future expected credit losses on mezzanine loans and revolving lines of credit are calculated on an individual loan basis or a borrower-specific basis for these types of loans. We use a combination of credit quality indicators in our models including, among others, the current payment status of the loans, the overall financial strength of the borrowers and any guarantors, historical information on any loan write-offs related to our borrowers and the nature, extent and value of underlying collateral on the loans. In addition, we adjust our models using the probability of default method related to any current economic or other conditions occurring or becoming known during the reporting period and any changes in our most recent forecasts that exist as of the end of the reporting period which impact our previous estimates of necessary credit loss reserves. For construction loans, we perform an assessment each reporting period end of the probability that we will acquire any properties in the event of default on any of these loans and, when necessary, reduce the basis of the applicable loans by the amounts that we expect to recover when construction of the applicable properties is complete.

Estimating our credit loss reserves involves significant judgment of our management. We may choose to perform additional qualitative assessments beyond those described above and apply adjustments as necessary in estimating our credit loss reserves. It is possible that our actual credit losses will differ materially from our estimates.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Fair Value Measurements*

Under GAAP, we are required to measure certain financial instruments at fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered hierarchy approach which requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs.

The three levels of inputs used to measure fair value in the GAAP hierarchy are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 measurements include inputs based on quoted prices in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 measurements include observable inputs, other than quoted prices described in Level 1 of the hierarchy, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active and other inputs that can be corroborated by observable market data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 measurements include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities including, but not limited to, pricing models, discounted cash flow methodologies and other similar techniques.

If the fair value measurement is based on inputs from different levels of the hierarchy, the level within which the entire fair value measurement falls is the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and consideration of factors specific to the asset or liability. When an event or circumstance alters our assessment of the observability and thus the appropriate classification of an input to a fair value measurement which we deem to be significant to the fair value measurement in its entirety, we disclose the transfer of the fair value measurement to the appropriate level within the hierarchy.

*Concentrations of Credit Risks*

We have credit risks related to our tenants, borrowers and managers. Our investment portfolio, consisting of real estate properties and mortgage and other notes receivable, subjects us to the possibility of incurring losses that may result from the failure of other parties to perform according to their contractual obligations with us or may result from a decline in market prices which may make our investments less valuable. Our mortgage and other notes receivable primarily consist of secured loans on healthcare facilities. We require collateral and other protective rights from our borrowers which we continually monitor to reduce our potential risks of incurring losses on these investments. Our management performs periodic reviews of our investments on an individual basis to assess for necessary reserves for potential losses.

We also have credit risks related to our cash and cash equivalents, which are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that may exceed federally insured limits. We have not experienced any losses related to these accounts.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Cash, Cash Equivalents and Restricted Cash*

The following table provides a reconciliation of cash, cash equivalents and restricted cash from our condensed consolidated statements of cash flows to the amounts presented on our condensed consolidated balance sheets (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Balances at the beginning of the period: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $19624 | $24289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash<sup>1</sup> |  | 2213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash | $19624 | $26502 |
| Balances at the end of the period: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $24948 | $135004 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash<sup>1</sup> |  | 2273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash | $24948 | $137277 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Restricted cash is included in other assets, net, on our condensed consolidated balance sheets.

*Noncontrolling Interests*

We assess our arrangements with noncontrolling interest holders to determine the appropriate balance sheet classification based on the redemption rights and other rights held by the noncontrolling interest holders. We recognize redeemable noncontrolling interests in the mezzanine section between liabilities and equity on our condensed consolidated balance sheets and all other noncontrolling interests are recognized in equity. We account for purchases or sales of equity interests that do not result in a change of control of the respective entity through capital in excess of par value on our condensed consolidated balance sheets. Net income (loss) attributable to noncontrolling interests is recognized each period as an adjustment to net income in determining the amount of net income (loss) available to our common stockholders.

Contingently redeemable noncontrolling interests are initially recognized at the greater of the initial carrying value or the redemption value and subsequently adjusted for contributions and distributions of the noncontrolling interest holders and their share of the respective partnership's net income or loss each period. In the period in which the contingency for redemption of the noncontrolling interest's shares is met or becomes probable of being met at a future date, we accrete the carrying value of the noncontrolling interest to the redemption value over the expected redemption period with an offsetting adjustment to capital in excess of par value.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Forward Equity Sales Transactions*

We have entered into, and may continue to enter into, forward equity sales agreements relating to the issuance of shares of our common stock, either through our at-the-market ("ATM") equity program or through underwritten public offerings. These agreements may be physically settled in our common stock, settled in cash or net share settled at our election. The forward sales price that we will receive upon physical settlement of a forward equity sales agreement will be subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate, less a spread adjustment, and (ii) scheduled dividends during the term of the forward equity sales agreement. To the extent a forward equity sales agreement does not meet all the criteria to qualify for equity treatment on our condensed consolidated balance sheets under ASC 815, Derivatives and Hedging ("ASC 815"), we recognize the change in its fair value during the period in net income in our condensed consolidated statements of income.

Shares issuable under a forward equity sales agreement are reflected in our diluted earnings per share calculations using the treasury stock method. Under this method, we increase basic weighted average common shares outstanding by the excess, if any, of the number of common shares that would be issued upon full physical settlement of our outstanding forward equity sales agreements over the number of common shares that could be purchased by us in the market utilizing the proceeds from the full physical settlement of the forward equity sales agreements.

*Management Fees*

We recognize the fees paid to the third-party managers of the real estate properties in our SHOP segment as expense over the period of the respective management contract with us. Generally, our management fee structure includes a base management fee of 5.0% of net revenue and may also include a real estate services fee of 5.0% of real estate costs incurred during any calendar year that exceed a threshold. Incentive management fees, if any, are recognized as expense beginning in the calendar year period in which we deemed it is more likely than not that the applicable threshold will be met.

*Share-Based Compensation Expense*

We measure and recognize share-based compensation expense upon issuing stock incentive awards based on the grant date fair value of the respective award which is amortized over the requisite service period in accordance with the term of each agreement. We estimate the fair values of stock options on the respective grant dates using the Black-Scholes option pricing model. The fair values of restricted stock awards ("RSA") are determined based on the closing market price of our common stock on the grant dates. We calculate the fair values of market-based restricted stock units ("RSU") using a Monte Carlo valuation model which assigns a weighted probability to the potential outcomes of our total stockholder return relative to the respective targets of each RSU as of the grant date. In this model, we take into consideration, among other things, assumptions related to interest rates, volatility and expected service periods which can fluctuate significantly year over year. We recognize forfeitures of our stock incentive awards as a reduction to share-based compensation expense in the periods in which they occur. Share-based compensation expense is recognized in general and administrative expenses in our condensed consolidated statements of income.

*Income Taxes*

We intend at all times to qualify as a REIT in accordance with the Internal Revenue Code. We will generally not be subject to U.S. federal income taxes provided that we continue to meet the necessary qualifications of a REIT. A failure to qualify with the applicable REIT rules and regulations would have a material adverse impact on our consolidated financial position, results of operations and cash flows.

Certain activities that we undertake may be conducted by subsidiary entities that have elected to be treated as taxable REIT subsidiaries ("TRS"). Accordingly, we include a provision for federal, state and local income taxes in our condensed consolidated financial statements, when applicable. The Internal Revenue Code percentage limit under the REIT asset test applicable to TRSs increased on January 1, 2026 from 20% to 25%.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Earnings Per Share*

Our unvested RSAs contain non-forfeitable rights to dividends, and accordingly these awards are deemed to be participating securities. As a result, we apply the two-class method in our calculations of basic and diluted earnings per share. Under the two-class method, we allocate net income to common stockholders and the holders of participating securities based on their respective weighted average shares outstanding and their respective participation rights to dividends declared and undistributed earnings. The computation of diluted earnings per share also includes the effect of all of our potentially dilutive securities issued.

*Recent Accounting Pronouncements Not Yet Adopted*

In November 2024, FASB issued Accounting Standards Update ("ASU") 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. which requires public entities to enhance transparency of income statement disclosures on an interim and annual basis by providing additional disaggregated information related to certain costs and expenses. In January 2025, the FASB issued ASU 2025-01, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarifies that the amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 with early adoption permitted. The amendments may be applied either prospectively or retrospectively. We are currently evaluating the potential impact of this guidance on our consolidated financial statements and related disclosures.

**Note 3. Real Estate Properties**

*Acquisitions*

During the three months ended March 31, 2026, we completed the following acquisitions of real estate properties (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | Buildings, | |
| | | | | | Building | |
| | | | | | Improvements | |
| | | Number of | Type of | | and Intangible | |
| Manager | Period | Properties | Property | Land | Assets | Total |
| SHOP segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Allegro Living Management | Q1 2026 | 9 | ALF | $9201 | $96287 | $105488 |

---

*Dispositions*

During the three months ended March 31, 2026, we completed the following disposition of a real estate property (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | Number of | Type of | Net | Net Carrying | Gain on |
| Operator | Period | Properties | Property | Proceeds | Amount | Disposition |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Brook Retirement Communities | Q1 2026 | 1 | SLC | $6662 | $4175 | $2487 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*National HealthCare Corporation ("NHC") Leased Portfolio Disposition*

On April 21, 2026, we executed a purchase and sale agreement with NHC/Op, L.P., a wholly owned subsidiary of NHC, and certain of its affiliates (collectively, the "NHC Purchaser") related to the sale of our entire portfolio of real estate properties leased to NHC, which includes 32 SNFs and three ILFs, for $560.0 million in net cash consideration. We anticipate closing the transaction on July 1, 2026, subject to certain customary closing conditions, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The NHC properties are included in our Real Estate Investments segment.

Pursuant to the terms of the purchase and sale agreement, contemporaneously with the closing of the transaction, we will execute a partial master lease termination and partial assignment and assumption of the master lease agreement which will result in the termination of our master lease agreement with NHC with respect to all properties, except for the four properties located in Florida that are subject to a sublease agreement. We will assign to the NHC Purchaser, and the NHC Purchaser will assume from us, the master lease for the four Florida properties. As of March 31, 2026, the aggregate net carrying amount of the NHC properties was $13.8 million.

*Second Quarter of 2026 Acquisitions and Dispositions*

In April 2026, we completed the sale of a property located in South Carolina upon the acceleration of an existing purchase option at the tenant's request. We received $3.2 million in net cash consideration and recognized a gain of $0.8 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $2.3 million. During each of the three months ended March 31, 2026 and 2025, we recognized rental income of $0.1 million related to this property.

In April 2026, we completed the sale of a property located in Ohio that was classified as assets held for sale as of March 31, 2026. We received $4.5 million in net cash consideration and recognized a gain of $0.9 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $3.6 million. During each of the three months ended March 31, 2026 and 2025, we recognized rental income of $0.2 million related to this property.

In May 2026, we completed the sale of a property located in Washington in which we had a purchase and sale agreement outstanding as of March 31, 2026. We received $39.0 million in net cash consideration and will recognize a gain of approximately $20.1 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $18.3 million. During the three months ended March 31, 2026 and 2025, we recognized rental income of $0.6 million and $0.7 million, respectively, related to this property.

In May 2026, we acquired a portfolio of seven SHOs located in Colorado with a combined total of 532 units. The total purchase price was $106.9 million, including closing costs. We acquired the portfolio using a qualified intermediary to facilitate a potential reverse exchange transaction under Section 1031 of the Internal Revenue Code ("Section 1031"). This portfolio of properties has been included in our SHOP segment and is being managed by Generations, LLC pursuant to a management agreement.

*Intangible Assets, Net*

We acquired intangible assets related to the fair values of in-place resident leases in connection with certain acquisitions of real estate properties in our SHOP segment. During the three months ended March 31, 2026, we recognized $1.5 million of amortization expense related to these intangible assets. During the three months ended March 31, 2025, we did not have any intangible assets included in real estate properties, net. As of March 31, 2026 and December 31, 2025, the net carrying amounts of these intangible assets were $5.6 million and $1.7 million, respectively.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

**Note 4. Mortgage and Other Notes Receivable**

We enter into financing arrangements with our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or other corporate needs and the acquisition of real estate properties. These investments are primarily secured loans guaranteed by significant parties to the notes or by cross-collateralization of properties with the same owner. Mortgage and other notes receivable are included in the Real Estate Investments segment. As of March 31, 2026, the principal amounts of our mortgage and other notes receivable totaled $159.6 million and $61.7 million, respectively. As of December 31, 2025, the principal amounts of our mortgage and other notes receivable totaled $154.3 million and $64.4 million, respectively. We had credit loss reserves of $15.3 million and $15.4 million as of March 31, 2026 and December 31, 2025, respectively, related to our mortgages and other notes receivable.

*Bickford Construction Loan and Mortgage Notes*

We have a fully funded construction loan with Bickford Senior Living ("Bickford") that is secured by a first mortgage lien on substantially all of the related real and personal property as well as a pledge of any and all leases or other agreements which may grant a right of use to the property. Pursuant to the loan agreement, Bickford is required to pay the related property taxes and insurance. The loan agreement contains a fair market value purchase option on the property that is available to us upon stabilization of the underlying operations. As of March 31, 2026, the principal amount outstanding on the construction loan was $14.7 million and the annual interest rate was 9.0%. In April 2026, the construction loan was modified to extend the maturity date by three years to July 2029.

As of March 31, 2026, we had an $11.7 million second mortgage note as a component of the purchase price consideration in connection with the sale of six properties to Bickford in 2021. This second mortgage note bears a 10.0% annual interest rate. In April 2026, the second mortgage note was modified to extend the maturity by three years to April 2029. We did not include this note receivable in the determination of the initial gain recognized on the sale of these properties and this mortgage note is not reflected in mortgage and other notes receivable, net, on the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025.

Reference the "Non-Performing Notes" section below related to the Bickford non-performing note.

*Senior Living Loans*

We have a $15.0 million revolving line of credit with Senior Living Communities, LLC ("Senior Living") that matures in December 2031. As of March 31, 2026, the principal amount outstanding on this revolving line of credit was $7.0 million and the annual interest rate was 8.0%. We also have a $1.5 million revolving line of credit with an affiliate of Senior Living that matures in October 2040. As of March 31, 2026, the annual interest rate on this revolving line of credit was 8.25%.

*Non-Performing Notes*

As of March 31, 2026, we had two loans designated as non-performing notes, consisting of an unsecured mezzanine loan with a principal balance of $12.0 million due from affiliates of Senior Living Management ("SLM") and an unsecured loan due from Bickford with a principal balance of $1.2 million. As of December 31, 2025, these loans had principal balances of $12.0 million and $1.3 million, respectively. These loans were fully reserved as of March 31, 2026 and December 31, 2025.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Credit Loss Reserves*

Our principal measures of credit quality related to our mortgage and other notes receivable, except for construction loans, are debt service coverage for amortizing loans and interest service or fixed charge coverage for non-amortizing loans (collectively, "Coverage"). A Coverage ratio provides a measure of the borrower's ability to make scheduled principal and interest payments. The Coverage ratios presented in the table below have been calculated utilizing the most recent date for which data is available, December 31, 2025, using EBITDARM (earnings before interest, taxes, depreciation, amortization, rent and management fees) and the requisite debt service, interest service or fixed charges, as defined in the applicable loan agreement. We categorize Coverage into three levels: (i) more than 1.5x, (ii) between 1.0x and 1.5x and (iii) below 1.0x. We update our calculations of Coverage on a quarterly basis. Coverage is not a meaningful credit quality indicator for construction loans as these developments are typically not generating any operating income or they have insufficient operating income because occupancy levels necessary to stabilize the properties have not yet been achieved. We measure the credit quality of construction loans by taking into consideration, among other things, the construction and stabilization timelines of the properties and the financial condition of the borrower, as well as current economic and market conditions. We consider the accounting guidance in ASC 310-20, Receivables — Nonrefundable Fees and Other Costs, when determining whether a modification, extension or renewal of a loan constitutes a current period origination.

The following table summarizes the credit quality indicators related to the principal amounts outstanding on our mortgage and other notes receivable as of March 31, 2026 (*$ in thousands*):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination |
| | 2026 | 2025 | 2024 | 2023 | 2022 | Prior<br>Years |<br>Total |
| Mortgage notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x | $— | $12587 | $27407 | $723 | $14756 | $— | $55473 |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x |  | 11144 | 24707 |  |  | 14700 | 50551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less than 1.0x |  | 18750 |  |  | 28442 | 6423 | 53615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage notes |  | 42481 | 52114 | 723 | 43198 | 21123 | 159639 |
| Mezzanine loans: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x |  | 1391 |  |  |  | 18734 | 20125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x |  |  |  | 799 |  | 6629 | 7428 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less than 1.0x |  |  |  |  |  | 9795 | 9795 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mezzanine loans |  | 1391 |  | 799 |  | 35158 | 37348 |
| Non-performing notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x |  |  | 1229 |  |  |  | 1229 |
| &nbsp;&nbsp;&nbsp;&nbsp;No coverage available |  |  |  |  |  | 12000 | 12000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-performing notes |  |  | 1229 |  |  | 12000 | 13229 |
| Revolving lines of credit: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x |  |  |  |  |  |  | 10724 |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x |  |  |  |  |  |  | 350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revolving lines of credit |  |  |  |  |  |  | 11074 |
| Credit loss reserves |  |  |  |  |  |  | (15341) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage and other notes |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receivable, net |  |  |  |  |  |  | $205949 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

Our methodology for estimating credit loss reserves on non-performing notes incorporates considerations of the sufficiency of the underlying collateral, current economic conditions and forecasts of future economic conditions that may impact the collectability of these notes, including qualitative factors, which may differ from conditions existing in the historical periods. Due to the continuing challenges in the U.S. financial markets and the potential impact on the collectability of our mortgage and other notes receivable, we forecasted a 20.0% increase in the probability of a default and a 20.0% increase in the amount of estimated loss from a default on all loans, other than those designated as non-performing notes which are fully reserved, resulting in an effective adjustment of 4.4% as of March 31, 2026.

The following table provides a summary of the change in our credit loss reserves for the three months ended March 31, 2026 (*$ in thousands*):

---

| | |
|:---|:---|
| Balance at the beginning of the period | $15397 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses (benefit) | (56) |
| Balance at the end of the period | $15341 |

---

**Note 5. Leases**

Our tenant leases are typically structured as triple-net leases and relate to single-tenant properties having an initial lease term of 10 years to 15 years with one or more five-year extension options. Most of our tenant leases contain annual rent escalators, which may be fixed or variable. Lease payments that are subject to a variable rent escalator are typically determined annually and calculated using a variable index, such as the consumer price index, or an index that is dependent on a future date and indeterminable at the inception of the lease.

A summary of our rental income with disaggregated information on our lease payments received during the period that were subject to fixed and variable rent escalators follows *($ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Lease payments based on fixed rent escalators | $64247 | $61690 |
| Lease payments based on variable rent escalators | 6101 | 3604 |
| Straight-line rent revenue adjustments | 723 | 1410 |
| Escrow funds received from tenants for |  |  |
| &nbsp;&nbsp;property operating expenses | 2804 | 2887 |
| Amortization of lease incentives | (725) | (725) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total rental income | $73150 | $68866 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Tenant Concentrations*

The following table provides information on the concentrations of our tenants, or affiliates of our tenants, which exceeded 10% of total revenues (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| | | | 2026 | 2026 | 2025 | 2025 |
| | Real<br>Estate<br>Properties<sup>1</sup> | Mortgage<br>and Other<br>Notes<sup>2</sup> |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |
| Senior Living | $633053 | $7000 | $14262 | 12.4% | $13727 | 15.4% |
| Bickford | 427237 | 15929 | 10858 | 9.4% | 10651 | 11.9% |
| NHC | 133770 |  | 11892 | 10.3% | 10785 | 12.1% |
| Escrow funds received from tenants for |  |  |  |  |  |  |
| &nbsp;&nbsp;property operating expenses |  |  | 2804 | 2.4% | 2887 | 3.2% |
| Other | 1459862 | 198361 | 38254 | 33.3% | 37307 | 41.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total tenant concentrations | $2653922 | $221290 | 78070 | 67.8% | 75357 | 84.4% |
| Resident fees and services<sup>4</sup> |  |  | 37060 | 32.2% | 13939 | 15.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues |  |  | $115130 | 100.0% | $89296 | 100.0% |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Real estate properties have been stated at their gross carrying amounts. Total real estate properties, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale and $742.5 million related to the properties in our SHOP segment.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Mortgage and other notes receivable have been stated at their gross carrying amounts. Total mortgage and other notes receivable, as presented in the table above, excludes our total credit loss reserves of $15.3 million.

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Revenues related to assets classified as held for sale are included in other revenues in the table above.

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>There are no concentrations in revenues from resident fees and services because the resident agreements at the senior housing communities in our SHOP segment are between us and the individual residents.

As of March 31, 2026 and December 31, 2025, our real estate properties in South Carolina represented 12.3% and 12.0% of our total real estate properties, net, on our condensed consolidated balance sheets. There were no other states where our geographical concentration in real estate properties was 10% or greater as of March 31, 2026 and December 31, 2025.

*Senior Living Leases*

As of March 31, 2026, we leased 11 SHOs with a combined total of 2,497 units to Senior Living. During the three months ended March 31, 2026 and 2025, we recognized straight-line rent revenue adjustments of $(0.4) million and $(0.2) million, respectively, related to our leases with Senior Living.

*Bickford Leases*

As of March 31, 2026, we leased 38 SHOs, including one property classified as assets held for sale, to Bickford under four master leases. In 2022, we began recognizing rental income from Bickford's leases using the cash basis of accounting for revenue recognition based upon information we obtained from Bickford regarding its financial condition that raised substantial doubt about its ability to continue as a going concern.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

In April 2026, we amended the four master lease agreements with Bickford increasing the combined base rent for the portfolio of 38 properties to $38.4 million annually. Future base rental income will escalate on an annual basis at a rate ranging between 2.0% and 3.0% in accordance with each amended lease agreement. These amendments also provide for a new contingent rent clause requiring Bickford to pay additional rent based on a percentage of its combined monthly revenues for all properties that are in excess of a base amount. Bickford will continue to be recognized as a cash basis tenant under the amended master lease agreements until the substantial doubt about its ability to continue as a going concern has been alleviated.

Additionally, we have an agreement with Bickford to fund up to $8.0 million of capital improvements on various properties in the Bickford portfolio. Pursuant to the terms of this agreement, rental income increases at an annual lease rate of 8.0% applied to the amount expended. In connection with the master lease amendments discussed above, we also amended this agreement in April 2026 to extend the available funding period through June 2027.

*NHC Lease*

As of March 31, 2026, we leased 32 SNFs and three ILFs to NHC, a publicly held company, under a triple-net master lease which expires in December 2026. Four of these properties have been subleased to other third parties pursuant to leases in which NHC serves as a guarantor. The triple-net master lease provides for a contingent rent clause that requires NHC to pay additional rent based on 4.0% of the excess, if any, in the annual revenues of the facilities it leases from us over a base amount specified in each lease. During each of the three months ended March 31, 2026 and 2025, we recognized straight-line rent revenue adjustments of $0.2 million related to NHC.

Reference the "NHC Leased Portfolio Disposition" section in Note 3 for information on the sale of the NHC properties.

The following table summarizes the portion of our rental income from NHC that was attributable to contingent rent for the periods indicated (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Current year | $2031 | $1618 |
| Prior year final certifications<sup>1</sup> | 1650 | 956 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contingent rental income from NHC | $3681 | $2574 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>NHC certifies the annual revenue of its facilities leased from us by March 31<sup>st</sup> of the following year.

One of the members of our board of directors is also the chairperson of NHC's board of directors. This director announced his resignation to be effective as of our 2026 annual meeting of stockholders in May 2026.

*Cash Basis Tenants*

During each of the three months ended March 31, 2026 and 2025, we had two tenants on the cash basis of accounting for revenue recognition.

A summary of lease payments received from cash basis tenants follows (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Bickford | $10205 | $9984 |
| Other | 1515 | 1480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease payments from cash basis tenants | $11720 | $11464 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Tenant Purchase Options*

Certain of our tenant leases contain a purchase option clause allowing the tenant to acquire the leased property at a fixed base price, a fixed base price plus a specified share in any appreciation of the property or a price based on a specified fixed minimum internal rate of return on our investment. As of March 31, 2026, tenants had purchase options on four of our properties, representing an aggregate net carrying value of $74.1 million, which have exercise dates ranging between 2026 and 2031. During each of the three months ended March 31, 2026 and 2025, rental income from these properties with tenant purchase options totaled $2.5 million.

Reference the "Second Quarter of 2026 Acquisitions and Dispositions" section in Note 3 of our condensed consolidated financial statements included in this Quarterly Report for information on the exercise of one of these tenant purchase options. As of March 31, 2026, we cannot reasonably estimate the probability that any of the remaining tenant purchase options will be exercised in the future.

*Future Minimum Lease Payments*

The fixed amounts of future minimum lease payments due to us under our existing tenant leases as of March 31, 2026 were as follows *($ in thousands*):

---

| | |
|:---|:---|
| Remainder of 2026 | $204313 |
| 2027 | 220250 |
| 2028 | 215007 |
| 2029 | 204373 |
| 2030 | 204024 |
| Thereafter | 834064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1882031 |

---

**Note 6. Equity Method Investment**

Concurrently with the acquisition of a continuing care retirement community ("CCRC") in January 2020 from LCS-Westminster Partnership III, LLP ("Timber Ridge CCRC"), we invested $0.9 million in the operating company, Timber Ridge OpCo, LLC ("Timber Ridge OpCo"), which represented a 25.0% equity interest. This investment is held by our TRS to be compliant with the provisions of the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA"). As part of our initial investment, we provided Timber Ridge OpCo with a revolving credit facility that has a maximum borrowing capacity of $5.0 million. As of March 31, 2026, no amounts have been drawn on this revolving credit facility.

We account for our investment in Timber Ridge OpCo under the equity method of accounting and decrease the carrying value of our investment for operating losses of the entity and distributions made to us for cumulative amounts up to and including our basis plus any guaranteed or implied commitments to fund operations. Our guaranteed and implied commitments are currently limited to the $5.0 million revolving credit facility and a $2.5 million lease incentive distribution received in February 2023. As of both March 31, 2026 and December 31, 2025, we have recognized our share of Timber Ridge OpCo's operating losses in excess of our initial investment. These cumulative losses of $5.0 million in excess of our original basis and the $2.5 million lease incentive distribution received are included in accounts payable and other liabilities on our condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025. During the three months ended March 31, 2026 and 2025, excess unrecognized equity method losses for this investment were $0.5 million and $0.6 million, respectively. As of March 31, 2026, our cumulative unrecognized losses for this investment were $18.6 million. During the three months ended March 31, 2025, we recognized a gain from equity method investment of $0.4 million related to cash distributions received from this investment. We did not receive any cash distributions from this investment during the three months ended March 31, 2026.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

The Timber Ridge OpCo property is subject to early resident mortgages secured by a Deed of Trust and Indenture of Trust (the "Deed and Indenture"). As part of our acquisition, NHI-LCS JV I, LLC ("Timber Ridge PropCo") acquired the Timber Ridge CCRC property and a subordination agreement was entered into pursuant to which the trustee acknowledged and confirmed that the security interests created under the Deed and Indenture were subordinate to any security interests granted in connection with the $81.0 million loan made by us to Timber Ridge PropCo, which is eliminated in our condensed consolidated financial statements. In addition, under the terms of the resident loan assumption agreements, during the term of the seven-year lease to Timber Ridge OpCo, which includes two five-year extension options, Timber Ridge OpCo is required to indemnify Timber Ridge PropCo for any repayment by Timber Ridge PropCo of these early resident mortgage liabilities under the guarantee. As a result of the subordination agreement and the resident loan assumption agreements, we have not recorded any liabilities as of March 31, 2026 and December 31, 2025. As of March 31, 2026, the balance secured by the Deed and Indenture was $7.6 million.

**Note 7. Other Assets, Net**

Other assets, net, consisted of the following (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | March 31,<br>2026 | December 31,<br>2025 |
| Real Estate Investments segment accounts receivable and other assets, net | $7051 | $3435 |
| SHOP segment accounts receivable, net of allowances of $168 and $309, respectively, |  |  |
| &nbsp;&nbsp;and other assets, net | 3306 | 3137 |
| Lease incentives, net | 4250 | 4976 |
| Regulatory escrows | 6208 | 6208 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets, net | $20815 | $17756 |

---

**Note 8. Debt, Net**

Our debt consisted of the following (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | March 31,<br>2026 | December 31,<br>2025 |
| Revolving credit facility - unsecured | $309000 | $204000 |
| Bank term loan - unsecured | 125000 | 125000 |
| 2031 Senior Notes - unsecured, net of discount of $1,554 and $1,635, respectively | 398446 | 398365 |
| 2033 Senior Notes - unsecured, net of discount of $3,578 and $3,707, respectively | 346422 | 346293 |
| Private placement notes - unsecured | 100000 | 100000 |
| Unamortized debt issuance costs | (9200) | (9844) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $1269668 | $1163814 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Debt Maturities*

A summary of the aggregate principal maturities of our outstanding debt as of March 31, 2026 follows (*$ in thousands*):

---

| | |
|:---|:---|
| Remainder of 2026 | $125000 |
| 2027 | 100000 |
| 2028 | 309000 |
| 2029 |  |
| 2030 |  |
| Thereafter | 750000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total principal amounts of debt outstanding | 1284000 |
| Less: Unamortized debt issuance costs and discounts | (14332) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $1269668 |

---

*Revolving Credit Facility and Bank Term Loan*

We have a $700.0 million unsecured revolving credit facility (the "Credit Facility") which matures in October 2028 and may be extended by us pursuant to (i) one or both of the six-month extension options or (ii) one 12-month extension option. We most recently amended the Credit Facility in October 2025 to remove the 0.10% credit spread adjustment applicable to the Secured Overnight Financing Rate ("SOFR") interest rates. Borrowings under the Credit Facility bear interest, at our election, at one of the following: (a) Term SOFR plus a margin ranging from 0.725% to 1.400%; (b) Daily SOFR plus a margin ranging from 0.725% to 1.400%; or (c) the base rate plus a margin ranging from 0.000% to 0.400%. In each election, the actual margin is determined according to our credit ratings. The base rate means, for any day, a fluctuating rate per annum equal to the highest of (x) the agent's prime rate, (y) the federal funds rate on such day plus 0.50% or (z) the adjusted Term SOFR for a one-month tenor in effect on such day plus 1.00%. In addition, the Credit Facility requires a facility fee equal to 0.125% to 0.300%, based on our credit rating on the $700.0 million committed capacity, without regard to usage.

As of March 31, 2026, we had $391.0 million available to draw on the Credit Facility, subject to usual and customary covenants. Among other stipulations, our Credit Facility requires that we maintain certain financial ratios within limits set by our creditors. As of March 31, 2026, we were in compliance with these covenants.

We have a $200.0 million unsecured bank term loan (the "Bank Term Loan"), which was most recently amended in October 2025 to remove the 0.10% credit spread adjustment applicable to the SOFR interest rates. The Bank Term Loan bears interest at a variable rate, which is SOFR-based with a margin determined according to our credit ratings, and matures in June 2026. As of March 31, 2026, we had $125.0 million of principal amount outstanding on the Bank Term Loan.

Pinnacle Bank is a participating member of our banking group. A member of our board of directors is also the chief banking officer and vice chairman of the board of directors of Pinnacle Financial Partners, Inc., the holding company for Pinnacle Bank. Our corporate banking transactions are conducted primarily through Pinnacle Bank.

*2031 Senior Notes*

In January 2021, we issued $400.0 million in aggregate principal amount of 3.00% unsecured senior notes that mature in February 2031 (the "2031 Senior Notes"). The 2031 Senior Notes were sold at an issue price of 99.196% of face value, before the underwriters' discount. Interest on the 2031 Senior Notes is due semi-annually. The 2031 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of March 31, 2026, we were in compliance with these covenants.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*2033 Senior Notes*

In September 2025, we issued $350.0 million in aggregate principal amount of 5.35% unsecured senior notes that mature in February 2033 (the "2033 Senior Notes"). The 2033 Senior Notes were sold at an issue price of 98.903% of face value, before the underwriters' discount. Interest on the 2033 Senior Notes began accruing in February 2026 and is due semi-annually. The 2033 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of March 31, 2026, we were in compliance with these covenants.

*Private Placement Notes*

Our private placement notes have a fixed interest rate and require interest only payments up to the maturity date. Covenants pertaining to the private placement notes are generally conformed with those governing our Credit Facility, except for specific debt coverage ratios that are more restrictive. Our private placement notes include a provision that increases the fixed interest rate if any rating agency lowers the credit rating on our unsecured senior debt below investment grade and our compliance leverage increases to 50% or more.

As of March 31, 2026, we had $100.0 million of principal amounts outstanding on our private placement notes which bears interest at 4.51% and mature in January 2027.

*Interest Expense* 

A summary of the components of interest expense follows *($ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Interest expense at contractual rates | $14186 | $13359 |
| Amortization of debt issuance costs and discounts | 854 | 978 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $15040 | $14337 |

---

**Note 9. Commitments, Contingencies and Uncertainties**

In the normal course of business, we enter into a variety of commitments, typically consisting of funding revolving credit arrangements, construction loans and mezzanine loans with our tenants, operators, or affiliates of our tenants or operators, and other third parties. In our leasing operations, we may offer our tenants and the sellers of properties we acquire certain inducements that originate contractually as contingencies, but which may become commitments upon the satisfaction of the contingent event. Any contingent payments made by us are included in the respective lease base when funded.

As of March 31, 2026, we had loan commitments with seven operators or borrowers totaling $113.1 million of which we had funded $80.7 million toward these commitments. We also had development commitments with six tenants totaling $22.6 million of which we had funded $12.9 million toward these commitments. Additionally, we had remaining contingency commitments totaling $15.7 million, which included lease inducement contingencies with three tenants and contingent consideration related to an acquisition in our SHOP segment. Each of these contingency commitments is based on the respective facility operating performance over a specified period.

We provide for expected credit loss liabilities on our unfunded loan commitments based on the estimated amounts we expect to fund using the same methodology as the one applied to provide for credit loss reserves on our mortgage and other notes receivable. The liabilities for expected credit losses on our unfunded loan commitments are included in accounts payable and other liabilities on our condensed consolidated balance sheets. Reference the "Credit Loss Reserves" section in Note 4 for additional information.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

The following table provides a summary of the change in our expected credit loss liabilities for the three months ended March 31, 2026 (*$ in thousands*):

---

| | |
|:---|:---|
| Balance at the beginning of the period | $152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for expected credit losses | 6 |
| Balance at the end of the period | $158 |

---

*Litigation*

From time to time, we are a party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

**Note 10. Noncontrolling Interests**

*Redeemable Noncontrolling Interest*

As of March 31, 2026, we had a portfolio of six ILFs located in California and Washington that are held in a consolidated partnership with Merrill Gardens, LLC ("Merrill"), which owns a 20.0% common equity interest in the partnership. We own 100% of the preferred equity interest and 80.0% of the common equity interest in the partnership. The operating agreement for the partnership provides for contingent distributions to the members based on the attainment of certain yields on the investment calculated on an annual basis. The Merrill consolidated partnership is included in our SHOP segment.

Certain provisions in the operating agreement entitle Merrill to put rights upon certain contingent events that are not solely within our control as the majority equity interest owner. As a result, Merrill's noncontrolling interest was deemed to be contingently redeemable and has been classified in the mezzanine section between liabilities and equity on our condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025. We are required to remeasure the carrying value of the noncontrolling interest to its redemption value in the period it becomes known that a triggering event is probable to occur. As of March 31, 2026 and December 31, 2025, we concluded that the redemption criteria were not met.

The following table provides a summary of the activity related to the redeemable noncontrolling interest for the three months ended March 31, 2026 (*$ in thousands*):

---

| | |
|:---|:---|
| Balance at the beginning of the period | $10195 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | (256) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared | (17) |
| Balance at the end of the period | $9922 |

---

*Noncontrolling Interests Classified as Equity*

In our Real Estate Investments segment, we own an 80.0% common equity interest in a partnership with LCS Timber Ridge LLC ("LCS"), which owns and leases a CCRC in Washington. LCS owns the remaining 20.0% common equity interest in the partnership.

Prior to August 1, 2025, we had a portfolio of six SHOs in a consolidated partnership in which we owned a 98.0% common equity interest and Discovery Senior Housing Investor, XXIV, LLC (the "Discovery partner") owned the remaining 2.0% of the common equity interest. This partnership was included in our Real Estate Investments segment prior to its dissolution on August 1, 2025.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

In our SHOP segment, we have a portfolio of 10 ILFs located in six states that are held in a consolidated partnership with a related party of Discovery Senior Living ("Discovery"). We own 100.0% of the preferred equity interest and 98.0% of the common equity interest in the partnership and the related party of Discovery owns the remaining 2.0% of the common equity interest. The operating agreement of the partnership provides for contingent distributions to the members based on the attainment of certain yields on the investment calculated on an annual basis.

**Note 11. Equity and Dividends**

*Shelf Registration Statement*

In March 2026, we renewed our automatic shelf registration statement on file with the SEC.

*ATM Equity Program*

We maintain an ATM equity program which allows us to sell our common stock directly into the market. This program is governed by an ATM equity sales agreement which includes a forward sales provision that allows us to sell shares of our common stock to forward purchasers at a predetermined price at a future date. Concurrently with the renewal of our shelf registration statement, we entered into a new equity distribution agreement whereby we can sell up to $500.0 million in common stock under our ATM equity program.

During the three months ended March 31, 2026, we did not enter into any new ATM forward equity sales agreements or settle any of our outstanding ATM forward equity sales agreements. As of March 31, 2026, we had the ability to access 0.6 million shares of our common stock at a weighted average price of $68.81 per share, net of sales agent fees, under remaining active ATM forward equity sales agreements which mature in the second quarter of 2026 and represent $44.2 million of undrawn net proceeds.

*Dividends*

On May 1, 2026, our board of directors declared a $0.92 per share dividend payable on August 7, 2026 to common stockholders of record as of June 30, 2026.

**Note 12. Share-Based Compensation**

Our outstanding stock incentive awards have been granted under the 2019 Stock Incentive Plan, as amended and restated (the "2019 Plan"). As of March 31, 2026, we had 2,957,004 shares of common stock available for future grants under the 2019 Plan.

*Share-Based Compensation Expense*

A summary of share-based compensation expense, net of forfeitures, by award type follows *($ in thousands)*:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Stock options | $1662 | $2334 |
| RSAs and RSUs | 578 | 224 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total share-based compensation expense | $2240 | $2558 |

---

As of March 31, 2026, we had unrecognized share-based compensation expense of $11.0 million that is expected to be recognized over the following years: $5.2 million in the remainder of 2026, $3.7 million in 2027, $2.0 million in 2028, $0.1 million in 2029 and less than $0.1 million in 2030.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Restricted Stock*

RSAs are service-based awards that ratably vest on each anniversary of the grant date over periods ranging from one year to five years. The holders of RSAs have a non-forfeitable right to dividends or dividend equivalents during the vesting periods. RSAs are subject to a one-year post-vesting hold period.

A summary of the activity related to our RSAs for the three months ended March 31, 2026 follows:

---

| | | |
|:---|:---|:---|
| |<br><br>Number of<br>Awards | Weighted<br>Average<br>Grant Date<br>Fair Value<br>Per Share |
| Unvested RSAs at the beginning of the period | 54100 | $64.29 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 39997 | 86.75 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested | (8900) | 68.09 |
| Unvested RSAs at the end of the period | 85197 | 74.43 |

---

RSUs are market-based awards issued to our executive officers and vest in their entirety at the end of a three-year period, subject to the performance of our total stockholder return as compared to certain pre-defined peer and industry groups. The number of shares of our common stock issued upon meeting the applicable thresholds can vary from 0.0% to 200.0% of the respective targets depending on the level of achievement reached. RSUs are subject to a one-year post-vesting hold period.

The following assumptions were used to estimate the fair value of our market-based RSUs granted during the three months ended March 31, 2026:

---

| | |
|:---|:---|
| Risk-free interest rate | 3.50% |
| Expected volatility | 21.3% |
| Expected service period | 2.8 years |

---

A summary of the activity related to our RSUs for the three months ended March 31, 2026 follows:

---

| | | |
|:---|:---|:---|
| |<br><br>Number of<br>Units | Weighted<br>Average<br>Grant Date<br>Fair Value<br>Per Share |
| Unvested RSUs at the beginning of the period |  | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 30085 | 111.28 |
| Unvested RSUs at the end of the period | 30085 | 111.28 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Stock Options*

The following assumptions were used to estimate the fair value of our stock options granted during the three months ended March 31, 2026:

---

| | |
|:---|:---|
| Risk-free interest rate | 3.94% |
| Expected volatility | 24.0% |
| Dividend yield | 5.2% |
| Expected lives | 2.9 years |

---

A summary of the activity related to our stock options for the three months ended March 31, 2026 follows:

---

| | | | |
|:---|:---|:---|:---|
| |<br><br>Number<br>of Options |<br>Weighted<br>Average<br>Exercise Price<br>Per Share | Weighted<br>Average<br>Remaining<br>Contractual<br>Life (Years) |
| Outstanding stock options at the beginning of the period | 1124499 | $66.39 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 328500 | 86.75 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercised | (704486) | 63.90 |  |
| Outstanding stock options at the end of the period | 748513 | 77.68 | 4.2 |
| Exercisable stock options at the end of the period | 372156 | 74.13 | 4.0 |

---

During the three months ended March 31, 2026, the weighted average fair value of options granted was $10.40 per share and the aggregate intrinsic value of stock options exercised was $12.0 million. As of March 31, 2026, the aggregate intrinsic values of our stock options outstanding and exercisable were $4.3 million and $3.1 million, respectively.

**Note 13. Earnings Per Share**

The following table presents the calculations of basic and diluted earnings per share *($ in thousands, except per share amounts)*:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Net income attributable to common stockholders | $40024 | $34113 |
| Weighted average common shares outstanding - basic | 48323945 | 45720496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options | 118603 | 120827 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward equity sales agreements | 105345 | 37205 |
| Weighted average common shares outstanding - diluted | 48547893 | 45878528 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.83 | $0.75 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.82 | $0.74 |
| Anti-dilutive stock options excluded from above | 14512 | 104699 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

**Note 14. Fair Value of Financial Instruments**

The carrying amounts of cash and cash equivalents, straight-line rents receivable, accounts receivable, accounts payable, other liabilities. dividends payable and deferred income approximate their fair values on our condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025.

The following table includes the carrying amounts and fair values of certain of our financial instruments (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Carrying Amounts | Carrying Amounts | Fair Values | Fair Values |
| | March 31,<br>2026 | December 31,<br>2025 | March 31,<br>2026 | December 31,<br>2025 |
| Level 2: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed rate debt, net | $839221 | $838764 | $795689 | $794233 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variable rate debt, net | 430447 | 325050 | 434000 | 329000 |
| Level 3: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage and other notes receivable, net | 205949 | 203296 | 203443 | 201490 |

---

We classify fixed rate debt as a Level 2 measurement. We determine the fair values of these debt instruments based on quoted prices for similar instruments or calculations utilizing model derived valuations in which significant inputs are observable in active markets.

We classify variable rate debt as a Level 2 measurement. We estimate the fair values of our borrowings under our Credit Facility and Bank Term Loan at their notional amounts due to the predominance of floating interest rates, which generally reflect market conditions.

We classify mortgage and other notes receivable, net, as Level 3 measurements. We estimate the fair values of these financial instruments using projected payoff valuations based on the expected future cash flows and credit risk of the borrower. If the repayment of a loan is expected to be provided solely from the collateral, we estimate the projected payoff of the loan based on the estimated fair value of the collateral, net of selling cost.

Our real estate properties and intangible assets are remeasured at fair value on a non-recurring basis. We classify these assets as Level 3 measurements. When indicators of potential impairment exists, we estimate the fair value of the identified asset or group of assets using the income approach and unobservable data, such as expected future cash flows, estimated capitalization and discount rates. We also consider national, regional and local industry market data, including comparable sales information, and may engage an external third-party appraiser to assist us in our estimations of fair value. We estimate the fair values of assets classified as held for sale based on our current sales price expectation, net of selling costs.

We did not remeasure the fair values of our real estate properties and intangible assets as of March 31, 2026 and December 31, 2025, except for the property reclassified to assets held for sale as of December 31, 2025, which was remeasured using the Level 3 measurements described above.

**Note 15. Segment Reporting**

We evaluate our business and make resource allocations based on two operating segments: Real Estate Investments and SHOP. The Real Estate Investments segment consists of our investments in acquiring SHOs and medical facilities and providing financing arrangements to our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or other corporate needs and the acquisition of real estate properties. We lease these properties primarily under triple-net leases and do not have involvement in the operations at the properties. The types of properties we acquire or finance include ILFs, ALFs, EFCs, SLCs, SNFs and HOSPs. Our SHOP segment consists of senior housing communities we own, which are operated on our behalf by third-party managers in exchange for a management fee.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

Our President and Chief Executive Officer serves as our Chief Operating Decision Maker ("CODM"). Our CODM reviews financial and other performance information quarterly based upon segment net operating income ("NOI"). We define NOI as total revenues less tenant reimbursements and property operating expenses. Our CODM evaluates NOI to make decisions about resource allocations to the segments and to assess the property level performance of our investment portfolios. The CODM evaluates revenues and operating expenses on a comparative basis for each segment, both sequentially and year-over-year, and also evaluates budget-to-actual variances on a quarterly basis. For our SHOP segment, the CODM reviews additional key performance indicators based on the revenues and operating expenses per occupied or available resident unit and based on revenues and functional expenses by resident.

We do not allocate non-property expenses to our operating segments in determining NOI. Our non-segment / corporate assets primarily include cash and cash equivalents, the corporate office and certain equipment.

On August 1, 2025, we entered into a series of concurrent transactions that included the transition of seven properties from the Real Estate Investments segment to the SHOP segment. The operating results of these properties have been reflected in the SHOP segment in the current year period and in the Real Estate Investments segment in the prior year period. There were no real estate property transitions in the three months ended March 31, 2026 and 2025. We do not have any other inter-segment transactions.

The following tables provide information on our operating segments (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| | Real Estate<br>Investments |<br>SHOP | Non-Segment /<br>Corporate |<br>Total |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income | $73150 | $— | $— | $73150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services |  | 37060 |  | 37060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income | 4920 |  |  | 4920 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 78070 | 37060 |  | 115130 |
| Utilities |  | 2471 |  | 2471 |
| Dietary |  | 2233 |  | 2233 |
| Labor |  | 14699 |  | 14699 |
| Taxes and insurance | 2804 | 2897 |  | 5701 |
| Management fees |  | 1946 |  | 1946 |
| Other senior housing operating expenses<sup>1</sup> |  | 3923 |  | 3923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOI | 75266 | 8891 |  | 84157 |
| Depreciation and amortization | 16562 | 7114 | 15 | 23691 |
| Interest expense |  |  | 15040 | 15040 |
| Legal expense |  |  | 305 | 305 |
| Franchise, excise and other taxes |  |  | 215 | 215 |
| General and administrative expenses |  |  | 7851 | 7851 |
| Loan and realty gains, net | (50) |  |  | (50) |
| Gains on dispositions of real estate properties, net | (2612) |  |  | (2612) |
| Other non-operating income | (35) |  |  | (35) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $61401 | $1777 | $(23426) | $39752 |
| Capital expenditures | $1118 | $108293 | $14 | $109425 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Amount includes general and administrative costs and marketing expenses.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| | Real Estate<br>Investments |<br>SHOP | Non-Segment /<br>Corporate |<br>Total |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income | $68866 | $— | $— | $68866 |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services |  | 13939 |  | 13939 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income | 6491 |  |  | 6491 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 75357 | 13939 |  | 89296 |
| Utilities |  | 1097 |  | 1097 |
| Dietary |  | 1045 |  | 1045 |
| Labor |  | 4299 |  | 4299 |
| Taxes and insurance | 2887 | 1538 |  | 4425 |
| Management fees |  | 691 |  | 691 |
| Other senior housing operating expenses<sup>1</sup> |  | 2183 |  | 2183 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NOI | 72470 | 3086 |  | 75556 |
| Depreciation and amortization | 16388 | 2758 | 11 | 19157 |
| Interest expense | 749 |  | 13588 | 14337 |
| Legal expense |  |  | 1426 | 1426 |
| Franchise, excise and other taxes |  |  | 269 | 269 |
| General and administrative expenses |  |  | 6829 | 6829 |
| Proxy contest and related expenses |  |  | 264 | 264 |
| Loan and realty gains, net | (14) |  |  | (14) |
| Gains on dispositions of real estate properties, net | (114) |  |  | (114) |
| Gains from equity method investment | (415) |  |  | (415) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $55876 | $328 | $(22387) | $33817 |
| Capital expenditures | $83730 | $1442 | $— | $85172 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Amount includes general and administrative costs and marketing expenses.

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

The following table provides a summary of our total assets by segment *($ in thousands)*:

---

| | | |
|:---|:---|:---|
| | March 31,<br>2026 | December 31,<br>2025 |
| Real Estate Investments segment | $2267443 | $2282128 |
| SHOP segment | 606271 | 503201 |
| Non-segment / corporate | 16151 | 11558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2889865 | $2796887 |

---

**Note 16. Variable Interest Entities**

*Consolidated VIEs*

We are the controlling equity partner in certain entities that we have deemed to be VIEs. For each of these partnerships, we determined whether either the members as a group lack the characteristics of a controlling financial interest or the total equity at risk in the individual partnership is insufficient to finance the activities of the partnership without additional subordinated financial support. We are deemed the primary beneficiary of these VIEs because we have the ability to direct the activities that most significantly impact the economic performance of these partnerships and also have the obligation to absorb the losses of the partnership or have the right to receive benefits arising from the partnership, subject to limited protective rights extended to our partners for specified business decisions.

In February 2026, we acquired a portfolio of nine ALFs using special purpose entities ("SPE") owned by a qualified intermediary to facilitate a potential reverse exchange transaction under Section 1031, which would permit us to defer the income taxes on capital gains if we complete the pending reverse exchange transaction and take title to the acquired replacement properties within 180 days of completing the sale of the respective existing properties. We have determined the SPEs are VIEs due to the insufficiency of equity at risk. We are deemed the primary beneficiary of the SPEs as we retain both the economic and legal benefits and obligations related to these entities and, accordingly, have recognized the SPEs on a consolidated basis in our financial statements. Reference the "Acquisitions" section in Note 3 for additional information.

The following table provides information on the assets and liabilities of our consolidated VIEs *($ in thousands)*:

---

| | | |
|:---|:---|:---|
| | March 31,<br>2026 | December 31,<br>2025 |
| Real Estate Investments segment: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties, net | $111780 | $112717 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 981 | 1020 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rents receivable | 438 | 554 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 2116 | 2751 |
| SHOP segment: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties, net | 389775 | 290691 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 5899 | 8121 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 1449 | 1457 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 4482 | 5473 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

*(unaudited)*

*Unconsolidated VIEs*

In our Real Estate Investments segment, we have concluded that we are not the primary beneficiary for certain investments where we lack either directly or through related parties the power to direct the activities that most significantly impact the economic performance of these entities. We do not have any unconsolidated VIEs in our SHOP segment.

The following table provides a summary of our relationships and sources of exposure related to our unconsolidated VIEs as of March 31, 2026 (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Year |  |  |  | Maximum |  |
| of Initial |  | Source of | Carrying | Exposure | Note |
| Involvement | Name | Exposure | Amounts | to Loss | References |
| 2014 | Senior Living | Various<sup>1</sup> | $45801 | $55301 | Notes 4, 5 |
| 2016 | SLM | Note | 12000 | 12000 | Note 4 |
| 2018 | Bickford | Notes | 16043 | 27709 | Note 4 |
| 2019 | Encore Senior Living | Various<sup>2</sup> | 48224 | 63455 | N/A |
| 2020 | Timber Ridge OpCo | Various<sup>3</sup> | (4946) | 54 | Note 6, 7 |
| 2020 | Senior Living Hospitality Group | Various<sup>1</sup> | 12580 | 13854 | N/A |
| 2021 | Montecito Medical Real Estate | Notes | 6682 | 6682 | N/A |
| 2021 | Vizion Health | Various<sup>1</sup> | 18433 | 18433 | N/A |
| 2021 | Navion Senior Solutions | Various<sup>4</sup> | 7183 | 9333 | N/A |
| 2023 | Kindcare Senior Living | Notes<sup>5</sup> | 830 | 830 | N/A |
| 2024 | Mainstay Healthcare | Note | 9066 | 9066 | N/A |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Note(s) and straight-line rents receivable

<sup>2</sup>&nbsp;&nbsp;&nbsp;&nbsp;Note, straight-line rents receivable and interest receivable

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Loan commitment, equity method investment, straight-line rents receivable and unamortized lease incentive

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>Straight-line rents receivable and unamortized lease incentive

<sup>5&nbsp;&nbsp;&nbsp;&nbsp;</sup>Two mezzanine loans originating from the sales of real estate properties

We are not obligated to provide support beyond our stated commitments to these tenants and borrowers whom we classify as VIEs and accordingly, our maximum exposure to loss as a result of these relationships is limited to the amounts of our commitments. Our risk of economic loss on a tenant lease in excess of what is presented in the table above is limited to any future non-payments of rent before we are able to take effective remedial action, as well as any costs incurred to secure a new lease at the property. The potential extent of such losses at a future date would depend upon facts and circumstances unique to each tenant and the related lease and therefore are not included in the table above.

In the future, we may be deemed the primary beneficiary of the operations if the tenants or borrowers do not have adequate liquidity to accept the risks and rewards as the tenants and operators of the properties, and we may be required to consolidate the financial position and results of operations of the tenants or borrowers.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

Unless the context otherwise requires, references throughout this document to "NHI" or the "Company" include National Health Investors, Inc., and its consolidated subsidiaries. In accordance with the "Plain English" guidelines of the Securities and Exchange Commission ("SEC"), this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026 ("Quarterly Report") has been written in the first person. In this document, the words "we", "our", "ours" and "us" refer only to National Health Investors, Inc. and its consolidated subsidiaries and not any other person.

**Cautionary Statement Regarding Forward-Looking Statements**

This Quarterly Report and other materials we have filed or may file with the SEC, as well as information included in oral statements made, or to be made, by our senior management, contain certain "forward-looking statements" as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, funds from operations, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as "may", "will", "should", "believes", "anticipates", "expects", "intends", "estimates", "plans", "projects", "target", "likely" and other similar expressions, are forward-looking statements.

Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in forward-looking statements as a result of factors including, but not limited to, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the operating success of our tenants, managers and borrowers, and if their financial condition or business prospects deteriorate, our business, financial condition and results of operations could be adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our tenants, managers and borrowers may become subject to bankruptcy or insolvency proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio, and the failure of any of these tenants to meet their obligations to us could materially and adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unable to replace our managers if the management agreements are terminated or not renewed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Actual or perceived risks associated with pandemics, epidemics or outbreaks have had, and may in the future have, a material adverse effect on our operators' businesses and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A member of our board of directors is also the chairperson of the board of directors of National HealthCare Corporation ("NHC"), and his interests may differ from those of our stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to risks related to government regulations and payors, principally Medicare and Medicaid, and the effect of changes to laws, regulations and reimbursement rates on the businesses of our tenants, managers and borrowers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The cash flows of our tenants, managers and borrowers may be adversely affected by increased liability claims and liability insurance costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant legal or regulatory proceedings could adversely affect the liquidity, financial condition and results of operations of our tenants, managers and borrowers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be fully indemnified by our tenants, managers and borrowers against future litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the success of property development and construction activities, which may fail to achieve the operating results we expect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our investments are concentrated in healthcare properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks related to our investment with Life Care Services for Timber Ridge, an entrance fee continuing care retirement community ("CCRC"), associated with Type A benefits offered to the residents of the CCRC and the related accounting requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Risks related to our joint venture investments could adversely affect our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inflation and increased interest rates may adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions, could adversely affect our business, financial condition, results of operations or prospects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse geopolitical developments could have a material adverse impact on our business;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to operational risks with respect to our senior housing operating portfolio ("SHOP") structured communities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A cybersecurity incident or other form of data breach involving our business and its information could cause a loss of confidential consumer and other personal information, give rise to remediation and other expenses, expose us to liability under privacy and security and consumer protection laws, subject us to federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to risks related to environmental laws and the costs associated with liabilities related to hazardous substances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks of damage from catastrophic weather and other natural or man-made disasters and the physical effects of climate change;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the success of our future acquisitions and investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Competition for acquisitions may result in increased market prices for properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on our ability to retain our management team and other personnel, and our ability to attract suitable replacements should any such personnel leave;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to the risk that our assets may be subject to impairment charges;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Stockholder activism efforts could cause us to incur substantial costs, divert management's attention and have an adverse effect on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to raise capital through equity sales is dependent, in part, on the market price of our common stock, and our failure to meet market expectations with respect to our business, or other factors we do not control, could negatively impact such market price and availability of equity capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The United States ("U.S.") federal income tax treatment of the cash that we might receive from cash settlement of our forward equity sales agreements is unclear and could jeopardize our ability to meet the real estate investment trust ("REIT") qualification requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our use of artificial intelligence could expose us to various risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* We may need to refinance existing debt or incur additional debt in the future, which may not be available on terms acceptable to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have covenants related to our indebtedness which impose certain operational limitations, and a breach of those covenants could materially adversely affect our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Downgrades in our credit ratings could have a material adverse effect on our costs and availability of capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on external sources of capital to fund our future capital needs, and if we encounter difficulty in obtaining such capital, we may not be able to make future investments necessary to grow our business or meet maturing commitments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt used to finance those investments bears interest at variable rates, which subjects us to interest rate risk;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* We depend on the ability to continue to qualify for taxation as a REIT for U.S. federal income tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• There are no assurances of our ability to pay dividends in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Complying with REIT requirements may cause us to forego otherwise attractive acquisition opportunities or liquidate otherwise attractive investments, which could materially hinder our performance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ownership of and relationship with any taxable REIT subsidiaries ("TRS") that we have formed, or will form, will be limited, and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legislative, regulatory or administrative tax changes could adversely affect us or our security holders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* We have ownership limits in our charter with respect to our common stock and other classes of capital stock which may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to certain provisions of Maryland law and in our charter and bylaws that could hinder, delay or prevent a change in control transaction, even if the transaction involves a premium price for our common stock or our stockholders believe such transaction to be otherwise in their best interests;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to complete the pending sale of the NHC properties could have an adverse effect on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The market price of our common stock may decline as a result of the sale of the NHC properties; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be able to successfully redeploy the net proceeds from the sale of the NHC properties in a manner that generates comparable returns.

Reference "Part I, Item 1, Business", "Part I, Item 1A, Risk Factors" and the notes to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025 ("Annual Report") and additionally "Part II, Item 1A, Risk Factors" in this Quarterly Report for a further discussion of these risks, various governmental regulations and other operating factors relating to the healthcare industry and the risk factors inherent therein. You should carefully consider these risks before making any investment decisions related to us. These risks and uncertainties are not the only ones facing us. There may be additional risks that we do not presently know of and/or that we currently deem immaterial. If any of the risks actually occur, our business, financial condition, results of operations and cash flows could be materially and adversely affected. In that case, the market price of our common stock could decline, and you may lose part or all of your investment. Given these risks and uncertainties, we can give no assurance that these forward-looking statements will, in fact, occur. We caution readers not to place undue reliance on such forward-looking statements, which speak only as of the dates made. We undertake no obligation to revise or update any of the forward-looking statements to reflect subsequent events or circumstances except to the extent required by applicable law.

**Executive Overview**

National Health Investors, Inc., established in 1991 as a Maryland corporation, is a self-managed REIT. We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and SHOP. Our investments in senior housing communities, also referred to as senior housing properties ("SHO"), include independent living facilities ("ILF"), assisted living facilities ("ALF"), entrance fee communities ("EFC") and senior living campuses ("SLC"). Our investments in medical facilities include skilled nursing facilities ("SNF") and hospitals ("HOSP").

In our Real Estate Investments segment, our revenues primarily relate to triple-net leases with third-party operators at our properties. Additionally, we recognize interest income from financing arrangements we provide to our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or other corporate needs and the acquisition of real estate properties. In our SHOP segment, we own and operate senior housing communities and generate revenues from resident fees and services. We utilize third-party managers to operate these properties on our behalf and pay a management fee for these services. Our investments across both segments are funded primarily through (i) operating cash flows, (ii) debt offerings, revolving lines of credit and term loans and (iii) sales of equity securities.

*NHC Leased Portfolio Disposition*

On April 21, 2026, we executed a purchase and sale agreement with NHC/Op, L.P., a wholly owned subsidiary of NHC, and certain of its affiliates (collectively, the "NHC Purchaser") related to the sale of our entire portfolio of real estate properties leased to NHC, which includes 32 SNFs and three ILFs, for $560.0 million in net cash consideration. We anticipate closing the transaction on July 1, 2026, subject to certain customary closing conditions, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The NHC properties are included in our Real Estate Investments segment.

Pursuant to the terms of the purchase and sale agreement, contemporaneously with the closing of the transaction, we will execute a partial master lease termination and partial assignment and assumption of the master lease agreement which will result in the termination of our master lease agreement with NHC with respect to all properties, except for the four properties located in Florida that are subject to a sublease agreement. We will assign to the NHC Purchaser, and the NHC Purchaser will assume from us, the master lease for the four Florida properties. As of March 31, 2026, the aggregate net carrying amount of the NHC properties was $13.8 million.

------

*Real Estate Investments Portfolio*

As of March 31, 2026, our investments comprising the Real Estate Investments segment included real estate properties and financing arrangements involving 188 properties located in 32 states, excluding one property classified as assets held for sale. The aggregate gross carrying value of these owned properties was $2.7 billion, which included 109 SHOs, 65 SNFs and one HOSP leased to 30 tenants. The aggregate gross carrying value of our mortgage and other notes receivable was $221.3 million, excluding $15.3 million of credit loss reserves.

We classify our investments in real estate properties as either SHOs or medical facilities and further classify our SHOs as either need-driven or discretionary properties based on the differing credit risk profiles represented by the underlying revenue sources.

*Need-Driven Senior Housing -* Need-driven SHOs include ALFs and SLCs which primarily attract private payment for services from residents who require assistance with activities of daily living. Need-driven properties are subject to regulatory oversight.

*Discretionary Senior Housing -* Discretionary SHOs include ILFs and EFCs which primarily attract private payment for services from residents who are making the lifestyle choice of living in an age-restricted, multi-family community that offers social programs, meals, housekeeping and, in some cases, access to healthcare services. Discretionary properties are subject to limited regulatory oversight. There is a correlation between demand for this type of community and the strength of the housing market.

*Medical Facilities -* Our medical facilities include SNFs and HOSPs that attract patients who have a need for acute or complex medical attention, preventative medicine or rehabilitation services. The operators of our medical facilities are generally paid for their services through a combination of private payor sources and government assistance programs, including Medicare and Medicaid. Medical facilities are subject to federal and state regulatory oversight and, in the case of hospitals, Joint Commission accreditation.

*Senior Housing Operating Portfolio* 

As of March 31, 2026, our SHOP segment investments included 35 senior housing communities located in 15 states and comprised of 17 ILFs, 11 SLCs and seven ALFs with a combined total of 3,469 units. The aggregate gross carrying value of these properties was $742.5 million. We have structured the operations at these senior housing communities to comply with the requirements of the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA"), and we utilize our TRS for activities that would otherwise be non-qualifying for REIT purposes.

The properties in our SHOP segment are operated by third-party managers in exchange for a management fee from us, and as such, we are not directly exposed to the credit risk of the managers in the same manner or to the same extent as the credit risk exposure we have related to our triple-net tenant leases. However, we rely on the managers' personnel, expertise, technology resources and information systems, proprietary information, good faith and judgment in operating our communities efficiently and effectively. We also rely on the managers to set appropriate resident fees and to operate our communities in compliance with the terms of our management agreements and all applicable laws and regulations.

**Critical Accounting Policies and Estimates**

There have been no significant changes to our critical accounting policies and estimates from the information provided in "Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report.

------

**Investment Portfolio Summary**

The following table provides a summary of the investment portfolios of our Real Estate Investments and SHOP segments by property type as of March 31, 2026 and for the three months ended March 31, 2026 (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties<sup>1</sup> |<br>Number of<br>Beds / Units | Net<br>Operating<br>Income<br>("NOI") |% of<br>Total NOI |<br>Gross<br>Carrying<br>Amounts<sup>2</sup> |
| Real Estate Investments segment: |  |  |  |  |  |
| &nbsp;&nbsp;Real estate properties: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - need-driven: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities | 86 | 4704 | $23897 | 28.4% | $1065419 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses | 8 | 1031 | 3617 | 4.3% | 173355 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing - need-driven | 94 | 5735 | 27514 | 32.7% | 1238774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - discretionary: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities | 3 | 273 | 405 | 0.5% | 9233 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entrance fee communities | 12 | 3208 | 17237 | 20.5% | 805621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing - discretionary | 15 | 3481 | 17642 | 21.0% | 814854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing | 109 | 9216 | 45156 | 53.7% | 2053628 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medical facilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Skilled nursing facilities | 65 | 8565 | 23609 | 28.1% | 557996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hospitals | 1 | 71 | 1075 | 1.3% | 42298 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total medical facilities | 66 | 8636 | 24684 | 29.4% | 600294 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  |  | 506 | 0.6% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 175 | 17852 | 70346 | 83.7% | 2653922 |
| &nbsp;&nbsp;Mortgage and other notes receivable: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - need-driven | 8 | 591 | 2293 | 2.7% | 106330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - discretionary | 1 | 141 | 252 | 0.3% | 11144 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Skilled nursing facilities | 3 | 367 | 274 | 0.3% | 14755 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hospitals | 1 | 36 | 636 | 0.8% | 27407 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other notes |  |  | 1465 | 1.6% | 61654 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage and other notes receivable | 13 | 1135 | 4920 | 5.7% | 221290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Real Estate Investments segment | 188 | 18987 | 75266 | 89.4% | 2875212 |
| SHOP segment: |  |  |  |  |  |
| &nbsp;&nbsp;Real estate properties: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities | 17 | 1994 | 4021 | 4.8% | 415133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses | 11 | 1038 | 3464 | 4.1% | 244124 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities | 7 | 437 | 1406 | 1.7% | 83292 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total SHOP segment | 35 | 3469 | 8891 | 10.6% | 742549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investment portfolio | 223 | 22456 | $84157 | 100.0% | $3617761 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of March 31, 2026.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of March 31, 2026 and $15.3 million of credit loss reserves related to our mortgage and other notes receivable.

------

The following table provides a summary of the investment portfolios of our Real Estate Investments and SHOP segments by operator type as of March 31, 2026 and for the three months ended March 31, 2026 (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties<sup>1</sup> |<br>NOI<sup>2</sup> |% of<br>Total NOI | Gross<br>Carrying<br>Amounts<sup>2</sup> |
| Real Estate Investments segment: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Public | 60 | $20847 | 24.7% | $480022 |
| &nbsp;&nbsp;&nbsp;&nbsp;National chain (privately owned) | 10 | 4462 | 5.3% | 242308 |
| &nbsp;&nbsp;&nbsp;&nbsp;Regional | 110 | 46864 | 55.7% | 2047686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Small | 8 | 2584 | 3.1% | 105196 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | 509 | 0.6% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Real Estate Investments segment | 188 | 75266 | 89.4% | 2875212 |
| SHOP segment | 35 | 8891 | 10.6% | 742549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investment portfolio | 223 | $84157 | 100.0% | $3617761 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of March 31, 2026.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale and $15.3 million of credit loss reserves related to our mortgage and other notes receivable.

The following table provides a summary of the impact of acquired and transitioned properties on our SHOP segment as of March 31, 2026 and for the three months ended March 31, 2026 *($ in thousands):*

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties |<br>Number of<br>Units |<br>NOI | Gross<br>Carrying<br>Amounts |
| Properties in SHOP segment since January 1, 2025 | 15 | 1732 | $3012 | $372217 |
| Acquisitions | 13 | 799 | 2977 | 180083 |
| Transitioned properties | 7 | 938 | 2902 | 190249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SHOP segment | 35 | 3469 | $8891 | $742549 |

---

The following table provides a summary of our NOI based on geographical location (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| South Carolina | $10430 | $9339 |
| Texas | 7901 | 7977 |
| Florida | 7807 | 6788 |
| North Carolina | 5940 | 5957 |
| Tennessee | 5914 | 5049 |
| All others | 46165 | 40404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total NOI | $84157 | $75514 |

---

As of March 31, 2026, our average effective annualized NOI for leased properties in our Real Estate Investments segment was $20,322 per unit for ALFs, $14,031 per unit for SLCs, $5,935 per unit for ILFs, $21,492 per unit for EFCs, $11,026 per bed for SNFs and $60,574 per bed for HOSPs. As of March 31, 2026, the average effective annualized NOI for our SHOP segment was $11,165 per unit.

------

Substantially all of our revenues and cash flows from operations are derived from rental income on tenant leases at our real estate properties, service fees on resident agreements at our senior housing communities and interest income earned on our mortgage and other notes receivable. These revenues are the primary sources of liquidity we use to fund our distributions to stockholders, the amounts of which depend on the performance of the operators and managers of our facilities. Any operating difficulties experienced by these parties could have a material adverse effect on their ability to meet financial and other contractual obligations with us and therefore may negatively impact our results of operations. We monitor the performance of our operators and managers through periodic reviews of their operating results and covenant compliance and through property inspections, among other activities.

**Recent Investments Activity**

*Acquisitions*

During the three months ended March 31, 2026, we completed the following acquisitions of real estate properties (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | Buildings, | |
| | | | | | Building | |
| | | | | | Improvements | |
| | | Number of | Type of | | and Intangible | |
| Manager | Period | Properties | Property | Land | Assets | Total |
| SHOP segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Allegro Living Management | Q1 2026 | 9 | ALFs | $9201 | $96287 | $105488 |

---

*Dispositions*

During the three months ended March 31, 2026, we completed the following disposition of a real estate property (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | Number of | Type of | Net | Net Carrying | Gain on |
| Operator | Period | Properties | Property | Proceeds | Amount | Disposition |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Brook Retirement Communities | Q1 2026 | 1 | SLC | $6662 | $4175 | $2487 |

---

Reference the "NHC Leased Portfolio Disposition" section in Note 3 of our condensed consolidated financial statements included in this Quarterly Report for information on the sale of the NHC properties.

*Second Quarter of 2026 Acquisitions and Dispositions*

In April 2026, we completed the sale of a property located in South Carolina upon the acceleration of an existing purchase option at the tenant's request. We received $3.2 million in net cash consideration and recognized a gain of $0.8 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $2.3 million. During each of the three months ended March 31, 2026 and 2025, we recognized rental income of $0.1 million related to this property.

In April 2026, we completed the sale of a property located in Ohio that was classified as assets held for sale as of March 31, 2026. We received $4.5 million in net cash consideration and recognized a gain of $0.9 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $3.6 million. During each of the three months ended March 31, 2026 and 2025, we recognized rental income of $0.2 million related to this property.

------

In May 2026, we completed the sale of a property located in Washington in which we had a purchase and sale agreement outstanding as of March 31, 2026. We received $39.0 million in net cash consideration and will recognize a gain of approximately $20.1 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $18.3 million. During the three months ended March 31, 2026 and 2025, we recognized rental income of $0.6 million and $0.7 million, respectively, related to this property.

In May 2026, we acquired a portfolio of seven SHOs located in Colorado with a combined total of 532 units. The total purchase price was $106.9 million, including closing costs. We acquired the portfolio using a qualified intermediary to facilitate a potential reverse exchange transaction under Section 1031 of the Internal Revenue Code ("Section 1031"). This portfolio of properties has been included in our SHOP segment and is being managed by Generations, LLC pursuant to a management agreement.

*Bickford Lease and Loan Modifications*

In April 2026, we amended the four master lease agreements with Bickford Senior Living ("Bickford") increasing the combined base rent for the portfolio of 38 properties to $38.4 million annually. Future base rental income will escalate on an annual basis at a rate ranging between 2.0% and 3.0% in accordance with each amended lease agreement. These amendments also provide for a new contingent rent clause requiring Bickford to pay additional rent based on a percentage of its combined monthly revenues for all properties that are in excess of a base amount. Bickford will continue to be recognized as a cash basis tenant under the amended master lease agreements until the substantial doubt about its ability to continue as a going concern has been alleviated.

Additionally, we have an agreement with Bickford to fund up to $8.0 million of capital improvements on various properties in the Bickford portfolio. Pursuant to the terms of this agreement, rental income increases at an annual lease rate of 8.0% applied to the amount expended. In connection with the master lease amendments discussed above, we also amended this agreement in April 2026 to extend the available funding period through June 2027.

In April 2026, we also modified two of our loan agreements with Bickford to extend the maturities by three years. The maturity of a fully funded construction loan with Bickford was extended to July 2029. As of March 31, 2026, the principal amount outstanding on this construction loan was $14.7 million and the annual interest rate was 9.0%. Additionally, the maturity of a second mortgage note with Bickford was extended to April 2029. As of March 31, 2026, the principal amount outstanding on the second mortgage note was $11.7 million and the annual interest rate was 10.0%. The second mortgage note was not included on our condensed consolidated balance sheet as of March 31, 2026. Reference the "Bickford Construction Loan and Mortgage Notes" section in Note 4 of our condensed consolidated financial statements included in this Quarterly Report for additional information on this note.

*Impairments and Credit Loss Reserves*

In addition to inflation risk and the potential for increased interest rates, our tenants and borrowers experience periods of significant financial pressures and difficulties similar to those encountered by other healthcare operators. We believe the net carrying amounts of our real estate properties are recoverable and our mortgage and other notes receivable, net of credit loss reserves, are realizable and supported by the value of the underlying collateral as of March 31, 2026. However, it is possible that future events or circumstances could require us to make significant adjustments to our carrying amounts. Reference Notes 3 and 4 of our condensed consolidated financial statements included in this Quarterly Report.

During the three months ended March 31, 2026 and 2025, we did not recognize any impairment charges related to our long-lived assets. As of March 31, 2026, we had assets held for sale, net, of $3.6 million related to one property in our Real Estate Investments segment. During each of the three months ended March 31, 2026 and 2025, we recognized rental income of $0.2 million related to this property. In April 2026, we sold this property for $4.5 million in net cash consideration and recognized a gain of $0.9 million related to the sale.

Our mortgage and other notes receivable are stated net of credit loss reserves of $15.3 million on our condensed consolidated balance sheet as of March 31, 2026. Additionally, we have credit loss liabilities of $0.2 million related to the expected credit losses on the unfunded portion of our loan commitments outstanding as of March 31, 2026. We evaluate each of these estimates of credit loss reserves on a quarterly basis and make adjustments based on current circumstances as considered necessary.

------

**Tenant Leases**

Our tenant leases are typically structured as triple-net leases and relate to single-tenant properties having an initial lease term of 10 years to 15 years with one or more five-year extension options. As such, there may be reporting periods in which we experience few, if any, lease renewals or expirations. Most of our tenant leases contain annual rent escalators, which may be fixed or variable. Certain of our tenant leases provide for additional contingent rent based on a percentage of the tenant's revenues in excess of a specified threshold as defined in the lease agreement. We recognize the contractual amounts of base rental income on a straight-line basis over the initial term of a lease, subject to a collectability assessment.

*Tenant Concentrations*

The following table provides information on the concentrations of our tenants, or affiliates of our tenants, which exceeded 10% of total revenues (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| | | | 2026 | 2026 | 2025 | 2025 |
| | Real<br>Estate<br>Properties<sup>1</sup> | Mortgage<br>and Other<br>Notes<sup>2</sup> |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |
| Senior Living Communities |  |  |  |  |  |  |
| &nbsp;&nbsp;LLC ("Senior Living") | $633053 | $7000 | $14262 | 12.4% | $13727 | 15.4% |
| Bickford | 427237 | 15929 | 10858 | 9.4% | 10651 | 11.9% |
| NHC | 133770 |  | 11892 | 10.3% | 10785 | 12.1% |
| Escrow funds received from tenants for |  |  |  |  |  |  |
| &nbsp;&nbsp;property operating expenses |  |  | 2804 | 2.4% | 2887 | 3.2% |
| Other | 1459862 | 198361 | 38254 | 33.3% | 37307 | 41.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total tenant concentrations | $2653922 | $221290 | 78070 | 67.8% | 75357 | 84.4% |
| Resident fees and services<sup>4</sup> |  |  | 37060 | 32.2% | 13939 | 15.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues |  |  | $115130 | 100.0% | $89296 | 100.0% |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Real estate properties have been stated at their gross carrying amounts. Total real estate properties, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale and $742.5 million related to the properties in our SHOP segment.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Mortgage and other notes receivable have been stated at their gross carrying amounts. Total mortgage and other notes receivable, as presented in the table above, excludes our total credit loss reserves of $15.3 million.

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Revenues related to assets classified as held for sale are included in other revenues in the table above.

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>There are no concentrations in revenues from resident fees and services because the resident agreements at the senior housing communities in our SHOP segment are between us and the individual residents.

As of March 31, 2026 and December 31, 2025, our real estate properties in South Carolina represented 12.3% and 12.0% of our total real estate properties, net, on our condensed consolidated balance sheets. There were no other states where our geographical concentration in real estate properties was 10% or greater as of March 31, 2026 and December 31, 2025.

------

*Senior Living Leases*

As of March 31, 2026, we leased 11 SHOs with a combined total of 2,497 units to Senior Living. During the three months ended March 31, 2026 and 2025, we recognized straight-line rent revenue adjustments of $(0.4) million and $(0.2) million, respectively, related to our leases with Senior Living.

*Bickford Leases*

As of March 31, 2026, we leased 38 SHOs, including one property classified as assets held for sale, to Bickford under four master leases. In 2022, we began recognizing rental income from Bickford's leases using the cash basis of accounting for revenue recognition based upon information we obtained from Bickford regarding its financial condition that raised substantial doubt about its ability to continue as a going concern.

Reference the "Bickford Lease and Loan Modifications" section in the "Recent Investments Activity" section above related to the Bickford master lease amendments executed in April 2026.

*NHC Lease*

As of March 31, 2026, we leased 32 SNFs and three ILFs to NHC, a publicly held company, under a triple-net master lease which expires in December 2026. As previously discussed, on April 21, 2026, we entered into a purchase and sale agreement with a wholly owned subsidiary of NHC to sell our entire portfolio of NHC properties. We anticipate the transaction will close in the third quarter of 2026. Reference the "NHC Leased Portfolio Disposition" section in Note 3 of our condensed consolidated financial statements included in this Quarterly Report for information on the sale of the NHC properties.

*Cash Basis Tenants*

During each of the three months ended March 31, 2026 and 2025, we had two tenants on the cash basis of accounting for revenue recognition.

A summary of lease payments received from cash basis tenants follows (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Bickford | $10205 | $9984 |
| Other | 1515 | 1480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease payments from cash basis tenants | $11720 | $11464 |

---

*Tenant Purchase Options*

Certain of our tenant leases contain a purchase option clause allowing the tenant to acquire the leased property at a fixed base price, a fixed base price plus a specified share in any appreciation of the property or a price based on a specified fixed minimum internal rate of return on our investment. As of March 31, 2026, tenants had purchase options on four of our properties, representing an aggregate net carrying value of $74.1 million, which have exercise dates ranging between 2026 and 2031. During each of the three months ended March 31, 2026 and 2025, rental income from these properties with tenant purchase options totaled $2.5 million.

Reference the "Second Quarter of 2026 Acquisitions and Dispositions" section in Note 3 of our condensed consolidated financial statements included in this Quarterly Report for information on the exercise of one of these tenant purchase options. As of March 31, 2026, we cannot reasonably estimate the probability that any of the remaining tenant purchase options will be exercised in the future. Consideration to be received from the exercise of any one or more of these remaining tenant purchase options is expected to exceed the net carrying amounts of the respective property at the time of sale.

------

**Tenant Monitoring**

The following table provides a summary of the average occupancy rates related to properties leased to Senior Living and Bickford for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Number of<br>Properties |<br>Q1 2026 |<br>Q4 2025 |<br>Q3 2025 |<br>Q2 2025 |<br>Q1 2025 |
| Senior Living<sup>1</sup> | 10 | 86.6% | 84.9% | 83.9% | 83.9% | 84.3% |
| Senior Living | 11 | 86.6% | 84.9% | 83.9% | 83.8% | 84.2% |
| Bickford<sup>2</sup> | 38 | 84.2% | 83.9% | 86.1% | 85.2% | 85.0% |

---

<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;The occupancy rates exclude a 251-unit CCRC acquired in October 2025.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The number of properties related to Bickford includes one property classified as assets held for sale as of March 31, 2026.

The following table provides a summary of the average occupancy rates related to properties in our SHOP segment for the periods indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| Number of properties at the end of the period | 15 | 15 | 15 | 15 | 15 |
| SHOP segment<sup>1</sup> | 85.8% | 86.4% | 87.9% | 89.1% | 89.2% |
| Number of properties at the end of the period | 35 | 26 | 22 | 15 | 15 |
| Total SHOP segment | 86.6% | 86.9% | 87.2% | 89.1% | 89.2% |

---

<sup>1 &nbsp;&nbsp;&nbsp;&nbsp;</sup>The occupancy rates relate to the 15 real estate properties in the SHOP segment since January 1, 2025.

The operators of our properties in the Real Estate Investments segment report to us the results of their operations on a periodic basis, which we in turn subject to further analysis as a means of monitoring potential credit risks within our portfolio. We have identified EBITDARM, which is calculated as earnings before interest, taxes, depreciation, amortization, rent and management fees, as a primary performance measure for our tenants based on the operating results they have reported to us. We believe EBITDARM is useful in our most fundamental analyses, as it is a property-level measure of an operator's success, by eliminating the effects of the operator's method of acquiring the use of its assets (interest and rent), its non-cash expenses (depreciation and amortization) and expenses that are dependent on its level of success (income taxes), and also excluding the effect of the operator's payment of its management fees, as typically those fees are contractually subordinate to our lease payments. For operators of our EFCs, our calculation of EBITDARM includes other cash flow adjustments typical of the industry which may include, but are not limited to, net cash flows from entrance fees, amortization of deferred entrance fees, adjustments for tenant rent obligations and management fee true-ups. The eliminations and adjustments reflect covenants in our tenant leases and provide a comparable basis for assessing our various relationships.

We believe that EBITDARM is a useful way to analyze the cash potential of a group of assets. From EBITDARM, we calculate a coverage ratio (EBITDARM / cash rent) measuring the ability of the operator to meet its monthly obligations. In addition to EBITDARM and the coverage ratio, we rely on a careful balance sheet analysis and other analytical procedures to help us identify potential areas of concern relative to our operators' ability to generate sufficient liquidity to meet their obligations, including their obligations to continue to pay the amounts due to us. Typical among our operators is a varying lag in reporting to us the results of their operations. Across our portfolio, however, our operators report their operating results, typically within either 30 days or 45 days and at the latest, within 90 days of month end. For computational purposes, we exclude mortgage and other notes receivable and development and lease-up properties that have been in operation less than 24 months. For stabilized acquisitions in our portfolio less than 24 months and renewing leases with changes in scheduled rent, we include pro forma cash rent.

------

The following tables provides a summary of our portfolio coverage and occupancy ratios related to our Real Estate Investments segment by property type on a trailing 12-month basis as of December 31, 2025 and 2024, the most recent periods available, excluding mortgage and other notes receivable and development and lease-up properties operating less than 24 months. The tables include pro forma cash inflows from lease payments related to acquired properties that have stabilized operations and that have been in the portfolio less than 24 months.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Senior | | Medical | | | |
| **Ratios by property type:** | Housing | SNF | Non-SNF | Total |  |  |
| Number of properties | 107 | 68 | 1 | 176 |  |  |
| Q4 2025 coverage | 1.61x | 3.41x | 2.57x | 2.23x |  |  |
| Q4 2025 occupancy | 86.7% | 82.5% | 76.9% | 85.0% |  |  |
| Q4 2024 coverage | 1.49x | 3.07x | 2.83x | 2.05x |  |  |
| Q4 2024 occupancy | 86.0% | 83.1% | 77.6% | 84.6% |  |  |
|  |  |  |  | Discretionary |  |  |
|  |  | Need-Driven |  | (Excluding |  | Medical |
|  | Need- | (Excluding |  | Senior |  | (Excluding |
| **Ratios by property class:** | Driven | Bickford) | Discretionary | Living) | Medical | NHC) |
| Number of properties | 93 | 55 | 14 | 4 | 69 | 34 |
| Q4 2025 coverage | 1.49x | 1.38x | 1.78x | 2.27x | 3.37x | 2.53x |
| Q4 2025 occupancy | 86.6% | 87.5% | 86.9% | 91.3% | 82.4% | 79.4% |
| Q4 2024 coverage | 1.39x | 1.21x | 1.64x | 1.81x | 3.06x | 2.22x |
| Q4 2024 occupancy | 86.0% | 85.9% | 86.0% | 90.7% | 83.1% | 76.6% |
|  | Senior |  |  |  |  |  |
| **Ratios by customer:** | Living | Bickford<sup>1</sup> | NHC<sup>2</sup> |  |  |  |
| Number of properties | 11 | 38 | 35 |  |  |  |
| Q4 2025 coverage | 1.58x | 1.69x | 4.47x |  |  |  |
| Q4 2025 occupancy | 84.2% | 85.1% | 89.6% |  |  |  |
| Q4 2024 coverage | 1.55x | 1.69x | 4.11x |  |  |  |
| Q4 2024 occupancy | 83.2% | 86.2% | 88.6% |  |  |  |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Bickford's coverage ratio on a pro forma basis, which includes the impact of the April 2024 base rent increase, was 1.66x for the trailing 12 months ended December 31, 2024. Bickford's coverage ratios on a pro forma basis, which includes the impact of the April 2026 base rent increase, were 1.55x and 1.50x for the trailing 12 months ended December 31, 2025 and 2024, respectively.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>NHC's coverage ratios have been reported in the table above at a consolidated level for NHC. The occupancy ratios for SNFs have been reported in the table above using data available in NHC's public filings with the SEC.

Fluctuations in our portfolio coverage and occupancy ratios primarily result from market and economic trends, local market competition, new or changing regulatory factors and the operational success of our tenants. In addition to the analysis above, we also evaluate and make decisions with respect to our tenants at an individual lease level. Generally, we have security deposits and/or corporate guarantees in place with many of our tenants if lease payment shortfalls materialize. In some instances, we may require a tenant to increase their security deposit with us in an amount equal to the lease payment shortfall until the required tenant lease coverage ratio is met. We monitor economic and financial conditions and also use credit enhancements, such as requiring our tenants to maintain security deposits and corporate guarantees with us, to mitigate the impact of an economic downturn on our business. The metrics presented in the tables above do not reflect the presence of these security deposits.

------

**Results of Operations**

A summary of our operating results follows (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | |
| | March 31, | March 31, |<br>Variance |
| | 2026 | 2025 | $% |
| Revenues |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | $4674 | $647 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transitioned properties |  | 2136 | (100.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dispositions and assets held for sale | 206 | 308 | (33.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other tenant leases | 65468 | 62203 | 5.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash rental income | 70348 | 65294 | 7.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments | 723 | 1410 | (48.7)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Escrow funds received from tenants for |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;property operating expenses | 2804 | 2887 | (2.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | (725) | (725) | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total rental income | 73150 | 68866 | 6.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services | 37060 | 13939 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income from mortgage and other notes receivable | 4917 | 6449 | (23.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 3 | 42 | (92.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 115130 | 89296 | 28.9% |
| Expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | 4280 | 323 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other assets | 19411 | 18834 | 3.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total depreciation and amortization | 23691 | 19157 | 23.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 15040 | 14337 | 4.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior housing operating expenses | 28169 | 10853 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal expense | 305 | 1426 | (78.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 215 | 269 | (20.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 7851 | 6829 | 15.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses |  | 264 | (100.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes and insurance on leased properties | 2804 | 2887 | (2.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty gains, net | (50) | (14) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 78025 | 56008 | 39.3% |
| Gains on dispositions of real estate properties, net | 2612 | 114 | NM |
| Gains from equity method investment |  | 415 | (100.0)% |
| Other non-operating income | 35 |  | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 39752 | 33817 | 17.6% |
| Add: Net loss attributable to noncontrolling interests | 350 | 348 | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to stockholders | 40102 | 34165 | 17.4% |
| Less: Net income allocated to participating securities | (78) | (52) | 50.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | $40024 | $34113 | 17.3% |

---

NM - Not meaningful

------

Financial highlights for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rental income increased $4.3 million, or 6.2%, primarily due to $4.0 million of increased rental income from real estate properties in our Real Estate Investments segment that were acquired since January 1, 2025, partially offset by $2.1 million of rental income in the prior year period related to seven properties transitioned into the SHOP segment on August 1, 2025 from the Real Estate Investments segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Resident fees and services, less senior housing operating expenses, increased $5.8 million, consisting of a $2.9 million increase related to the transitioned properties discussed above and a $3.0 million increase due to acquisitions in our SHOP segment since January 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest income from mortgage and other notes receivable decreased $1.5 million, or 23.8%, primarily due to a net reduction in the principal amounts of mortgage and other notes receivable outstanding in the current period compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Depreciation and amortization increased $4.5 million, or 23.7%, which primarily related to the $4.0 million increase as a result of acquisitions since January 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest expense increased $0.7 million, or 4.9%, primarily due to interest expense associated with our 2033 Senior Notes, which were issued in September 2025, partially offset by a decrease in the amounts outstanding under our revolving credit facility and bank term loan in the current period compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legal expense decreased $1.1 million, or 78.6%. Legal expense for the three months ended March 31, 2025 included $1.2 million of costs related to a large SHOP transaction that did not materialize.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• General and administrative expenses increased $1.0 million, or 15.0%, primarily due to higher compensation costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Proxy contest and related expenses of $0.3 million for the three months ended March 31, 2025 consisted of proxy advisory costs related to our response to a proxy campaign associated with our 2025 annual meeting of stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains on dispositions of real estate properties, net, of $2.6 million for the three months ended March 31, 2026 primarily related to the sale of a SLC located in Michigan. This property was part of our Real Estate Investments segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains from equity method investment of $0.4 million for the three months ended March 31, 2025 related to cash distributions received from this investment with no comparable amount in the current period.

------

**Liquidity and Capital Resources**

As of March 31, 2026, we had $391.0 million available to draw on our $700.0 million revolving credit facility (the "Credit Facility"), $24.9 million in unrestricted cash and cash equivalents, the ability to access $44.2 million of undrawn net proceeds through at-the-market ("ATM") forward equity sales agreements and the ability to access $500.0 million through the issuance of common stock under our ATM equity program. In addition, we maintain an effective automatic shelf registration statement through which capital could be raised through the issuance of additional debt or equity securities.

*Sources and Uses of Funds*

Our primary sources of cash include lease payments from tenants, receipts from residents, principal and interest payments on mortgage and other notes receivable, proceeds from dispositions of real estate properties, net proceeds from offerings of debt and equity securities and borrowings from our Credit Facility. Our primary uses of cash include principal and interest payments on our debt, investments in new and existing real estate properties, mortgages and other notes, dividend distributions to our stockholders, operating expenses of our SHOP segment and general corporate overhead expenses.

A summary of our sources and uses of cash, cash equivalents and restricted cash follows (*$ in thousands):*

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | |
| | March 31, | March 31, |<br>Variances |
| | 2026 | 2025 | $% |
| Cash, cash equivalents and restricted cash |  |  |  |
| &nbsp;&nbsp;at the beginning of the period | $19624 | $26502 | (26.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 53440 | 46478 | 15.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (103886) | (75469) | 37.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 55770 | 139766 | (60.1)% |
| Cash, cash equivalents and restricted cash |  |  |  |
| &nbsp;&nbsp;at the end of the period | $24948 | $137277 | (81.8)% |

---

*Operating Activities –* Net cash provided by operating activities for the three months ended March 31, 2026 included the impact of new tenant leases from acquisitions completed since January 1, 2025, our SHOP segment operations and acquisitions, increased rental income due to rent escalators and interest payments on new loan investments completed since January 1, 2025.

*Investing Activities –* Net cash used in investing activities for the three months ended March 31, 2026 was comprised primarily of $114.4 million of investments in new real estate properties, development projects at existing properties, mortgages and other notes, partially offset by proceeds from the sale of a property in our Real Estate Investments segment and principal amounts received on mortgage and other notes receivable during the period.

*Financing Activities –* Net cash provided by financing activities for the three months ended March 31, 2026 included an $11.0 million decrease in the net borrowings on our Credit Facility compared to the prior year period. In addition, we had $65.5 million in net proceeds from the issuance of common shares in the prior year period with no comparable amount in the current period.

*Debt Obligations*

As of March 31, 2026, we had $1.3 billion of outstanding indebtedness. Reference "Part I, Item 3. Quantitative and Qualitative Disclosures About Market Risk" in this Quarterly Report for information on the impact of interest rate risk on our business.

------

*Revolving Credit Facility and Bank Term Loan -* We have a $700.0 million Credit Facility which matures in October 2028 and may be extended by us pursuant to (i) one or both of the six-month extension options or (ii) one 12-month extension option. We most recently amended the Credit Facility in October 2025 to remove the 0.10% credit spread adjustment applicable to the Secured Overnight Financing Rate ("SOFR") interest rates. Borrowings under the Credit Facility bear interest, at our election, at one of the following: (a) Term SOFR plus a margin ranging from 0.725% to 1.400%; (b) Daily SOFR plus a margin ranging from 0.725% to 1.400%; or (c) the base rate plus a margin ranging from 0.000% to 0.400%. In each election, the actual margin is determined according to our credit ratings. The base rate means, for any day, a fluctuating rate per annum equal to the highest of (x) the agent's prime rate, (y) the federal funds rate on such day plus 0.50% or (z) the adjusted Term SOFR for a one-month tenor in effect on such day plus 1.00%. In addition, the Credit Facility requires a facility fee equal to 0.125% to 0.300%, based on our credit rating on the $700.0 million committed capacity, without regard to usage.

As of March 31, 2026, we had $391.0 million available to draw on the Credit Facility, subject to usual and customary covenants. Among other stipulations, our Credit Facility requires that we maintain certain financial ratios within limits set by our creditors. As of March 31, 2026, we were in compliance with these covenants.

We have a $200.0 million unsecured bank term loan (the "Bank Term Loan"), which was most recently amended in October 2025 to remove the 0.10% credit spread adjustment applicable to the SOFR interest rates. The Bank Term Loan bears interest at a variable rate, which is SOFR-based with a margin determined according to our credit ratings, and matures in June 2026. As of March 31, 2026, we had $125.0 million of principal amount outstanding on the Bank Term Loan.

Pinnacle Bank is a participating member of our banking group. A member of our board of directors is also the chief banking officer and vice chairman of the board of directors of Pinnacle Financial Partners, Inc., the holding company for Pinnacle Bank. Our corporate banking transactions are conducted primarily through Pinnacle Bank.

We have provided summary information in the table below on the current SOFR credit spread adjustments and facility fee for our Credit Facility and Bank Term Loan reflecting our ratings compliance based on the applicable margin for SOFR loans with a debt rating of BBB-/Baa3:

---

| | | | |
|:---|:---|:---|:---|
| | SOFR Credit Spread Adjustments | SOFR Credit Spread Adjustments | SOFR Credit Spread Adjustments |
| | Credit | Credit | Bank |
| Debt Ratings | Facility | Facility Fee | Term Loan |
| A-/A3 | 0.725% | 0.125% | 0.850% |
| BBB+/Baa1 | 0.775% | 0.150% | 0.900% |
| BBB/Baa2 | 0.850% | 0.200% | 1.000% |
| BBB-/Baa3 | 1.050% | 0.250% | 1.250% |
| Lower than BBB-/Baa3 | 1.400% | 0.300% | 1.650% |

---

If our credit rating from at least two credit rating agencies is downgraded below "BBB-/Baa3", the debt under our debt agreements will be subject to defined increases in interest rates and fees.

*2031 Senior Notes -* In January 2021, we issued $400.0 million in aggregate principal amount of 3.00% unsecured senior notes that mature in February 2031 (the "2031 Senior Notes"). The 2031 Senior Notes were sold at an issue price of 99.196% of face value, before the underwriters' discount. Interest on the 2031 Senior Notes is due semi-annually. The 2031 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of March 31, 2026, we were in compliance with these covenants.

*2033 Senior Notes -* In September 2025, we issued $350.0 million in aggregate principal amount of 5.35% unsecured senior notes that mature in February 2033 (the "2033 Senior Notes"). The 2033 Senior Notes were sold at an issue price of 98.903% of face value, before the underwriters' discount. Interest on the 2033 Senior Notes began accruing in February 2026 and is due semi-annually. The 2033 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of March 31, 2026, we were in compliance with these covenants.

*Private Placement Notes -* As of March 31, 2026, we had $100.0 million of principal amounts outstanding on our private placement notes which bear interest at 4.51% and mature in January 2027.

*Debt Maturities -* Reference Note 8 of our condensed consolidated financial statements included in this Quarterly Report.

------

*Credit Ratings -* Moody's Investors Services reaffirmed its credit rating and a senior unsecured debt rating of Baa3 and "Stable" outlook on NHI on September 21, 2025. Fitch Ratings reaffirmed its public issuer credit rating of BBB- and "Stable" outlook on NHI on April 16, 2025 and S&P Global reaffirmed its BBB- rating and "Stable" outlook on NHI on October 6, 2025. Our unsecured private placement notes agreements include a rate increase provision that is effective if any rating agency lowers our credit rating below investment grade and our compliance leverage increases to 50% or more. Any reduction in outlook or downgrade in our credit ratings from the rating agencies could negatively impact our costs of borrowings.

*Debt Metrics -* We believe that our fixed charge coverage ratio, which is the ratio of Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, excluding impairments of real estate properties and gains on dispositions of real estate properties) to fixed charges (interest expense at contractual rates, net of capitalized interest and principal payments on debt), and the ratio of consolidated net debt (debt less cash and cash equivalents) to Adjusted EBITDA are meaningful measures of our ability to service our debt. We use these two measures as a useful basis to compare the strength of our consolidated balance sheet with those of our peer group. We also believe our consolidated balance sheet gives us a competitive advantage when accessing debt markets.

Our fixed charge coverage ratio was 5.4x for the three months ended March 31, 2026. Reference the "Adjusted EBITDA" section in the "Non-GAAP Financial Measures" section below for a table showing the fixed charge coverage ratio calculation. Giving effect to significant acquisitions, financing arrangements, dispositions and note payoffs on an annualized basis, our consolidated net debt to annualized Adjusted EBITDA ratio for the three months ended March 31, 2026 was as follows (*$ in thousands*):

---

| | |
|:---|:---|
| Consolidated Total Debt | $1269668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Cash and cash equivalents | (24948) |
| Consolidated Net Debt | $1244720 |
| Adjusted EBITDA | $76036 |
| &nbsp;&nbsp;&nbsp;&nbsp;Annualized adjustment | 228108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Annualized impact of recent investments, dispositions and note payoffs | 3458 |
| Annualized Adjusted EBITDA | $307602 |
| Consolidated Net Debt to Annualized Adjusted EBITDA | 4.0x |

---

*Supplemental Guarantor Financial Information*

The principal amounts outstanding on each of our debt instruments as of March 31, 2026 were fully and unconditionally guaranteed on a senior unsecured basis by each of our subsidiaries, except for certain excluded subsidiaries (the "Guarantors"). The Guarantors are either owned or controlled by, or are affiliates of, us.

The following tables present summarized financial information as of March 31, 2026 and for the three months ended March 31, 2026 for NHI and the Guarantors on a combined basis after eliminating (i) intercompany transactions and balances among the Guarantors and (ii) equity in earnings from, and any investments in, any subsidiary that is a non-guarantor *($ in thousands)*:

---

| | |
|:---|:---|
| Real estate properties, net | $2211789 |
| Other assets, net | 315419 |
| Note receivable due from a non-guarantor subsidiary | 81519 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2608727 |
| Debt, net | $1269668 |
| Other liabilities | 84822 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $1354490 |
| Redeemable noncontrolling interest | $9922 |
| Noncontrolling interests | 1226 |

---

------

---

| | |
|:---|:---|
| Revenues | $103841 |
| Interest income on a note receivable due from a non-guarantor subsidiary | 1477 |
| Expenses | 68804 |
| Gains on dispositions of real estate properties, net | 2612 |
| Other non-operating income | 26 |
| Net income | $39152 |
| Net income attributable to NHI and the subsidiary guarantors | $39503 |

---

*Equity and Dividends*

As of March 31, 2026, we had 48,459,369 shares of common stock outstanding with a market value of $3.9 billion. Total equity on our condensed consolidated balance sheet included in this Quarterly Report was $1.5 billion as of March 31, 2026.

*Shelf Registration Statement -* In March 2026, we renewed our automatic shelf registration statement, on file with the SEC, which allows us to offer and sell to the public an unspecified amount of common stock, preferred stock, debt securities, warrants and/or units at prices and on terms to be announced when and if such securities are offered. The details of any future offerings, along with the use of proceeds from any securities offered, will be described in a prospectus supplement, or other offering materials, at the time of the offering.

*ATM Equity Program -* We maintain an ATM equity program which allows us to sell our common stock directly into the market. This program is governed by an ATM equity sales agreement which includes a forward sales provision that allows us to sell shares of our common stock to forward purchasers at a predetermined price at a future date. Concurrently with the renewal of our shelf registration statement, we entered into a new equity distribution agreement whereby we can sell up to $500.0 million in common stock under our ATM equity program.

During the three months ended March 31, 2026, we did not enter into any new ATM forward equity sales agreements or settle any of our outstanding ATM forward equity sales agreements. As of March 31, 2026, we had the ability to access 0.6 million shares of our common stock at a weighted average price of $68.81 per share, net of sales agent fees, under remaining active ATM forward equity sales agreements which mature in the second quarter of 2026 and represent $44.2 million of undrawn net proceeds.

We use ATM equity program proceeds to rebalance our leverage in response to our acquisitions activity which keeps our alternatives flexible for financing further growth of our business. We have historically used proceeds from the ATM equity program for general corporate purposes, which may include future acquisitions and repayment of indebtedness, including borrowings under our Credit Facility. We view our ATM equity program as an effective way to match-fund our smaller acquisitions by exercising control over the timing and size of transactions and achieving a more favorable cost of capital as compared to larger follow-on offerings.

*Dividends* - Our board of directors approves a quarterly dividend which is reflective of expected taxable income on a recurring basis. Taxable income is determined in accordance with the Internal Revenue Code and differs from net income for financial statement reporting purposes that has been determined in accordance with U.S. generally accepted accounting principles ("GAAP"). Our board of directors has historically directed us towards maintaining a strong consolidated balance sheet. Therefore, we consider the competing interests of short-term and long-term debt interest rates, maturities and other terms versus the higher cost of new equity, and we accept some level of risk associated with leveraging our investments. We intend to continue to make new investments that meet our underwriting criteria and where the credit spread over our costs of equity and debt capital on a leverage-neutral basis will generate sufficient returns to our stockholders. We do not expect to utilize borrowings to satisfy the payment of dividends and project that our cash flows from operations will be adequate to fund dividends at the current rate.

We intend to comply with REIT dividend requirements that require us to distribute at least 90% of our annual taxable income for the year ended December 31, 2026 and thereafter. Historically, we have distributed at least 100% of our annual taxable income. Dividends declared for the fourth quarter of each fiscal year that are paid by the end of the following January are treated for federal income tax purposes, with some exceptions, as having been paid in the fiscal year just ended as provided in Section 857(b)(9) of the Internal Revenue Code. To the extent a portion, or all of such dividend, exceeds our current year earnings and profits, the excess is treated as having been received in the year paid for federal income tax purposes.

------

The following table summarizes dividends declared by our board of directors or paid by us for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| Date | Date | Date Paid | Quarterly Dividend |
| Declared | of Record | or Payable | Per Share |
| May 2, 2025 | June 30, 2025 | August 1, 2025 | $0.90 |
| August 5, 2025 | September 30, 2025 | October 31, 2025 | $0.92 |
| November 5, 2025 | December 31, 2025 | January 30, 2026 | $0.92 |
| February 17, 2026 | March 31, 2026 | May 1, 2026 | $0.92 |

---

On May 1 , 2026, our board of directors declared a $0.92 per share dividend payable on August 7, 2026 to common stockholders of record as of June 30, 2026.

*Material Cash Requirements* 

As of April 30, 2026, we had $33.5 million of cash and cash equivalents and $247.0 million of availability under our Credit Facility. Our expected material cash requirements for the 12-months ending March 31, 2027 and thereafter consist of long-term debt maturities, interest payments on our debt and other contractually obligated expenditures. We expect to meet our short-term liquidity needs largely through cash generated from operations, borrowings under our Credit Facility, settlements of ATM forward equity sales agreements and proceeds from dispositions of real estate properties, although we may choose to seek alternative sources of liquidity. Should we have additional liquidity needs, we believe that we could access long-term financing in the debt and equity capital markets.

We believe our current liquidity position, supplemented by our ability to generate positive cash flows from operations in the future, and our low net leverage will be sufficient to meet all of our short-term and long-term financial commitments.

*Contractual Obligations and Contingent Liabilities*

A summary of our contractual obligations as of March 31, 2026 follows *($ in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| |<br>Total | Less than<br>One Year | One Year<br>to Three Years | Three Years<br>to Five Years | More than<br>Five Years |
| Debt, including interest<sup>1</sup> | $1511995 | $276974 | $396135 | $457989 | $380897 |
| Loan commitments | 32354 | 31154 | 1200 |  |  |
| Development commitments | 9716 |  | 9716 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contractual obligations | $1554065 | $308128 | $407051 | $457989 | $380897 |

---

<sup>1</sup> Interest was calculated based on the weighted average interest rate applied to the principal amounts outstanding of our debt as of March 31, 2026. The calculation also includes a facility fee of 0.25% on the Credit Facility.

------

A summary of our outstanding loan commitments as of March 31, 2026 follows (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Type of<br>Property | Type of<br>Commitment | Total<br>Commitments |<br>Funded |<br>Remaining |
| &nbsp;&nbsp;&nbsp;&nbsp;Carriage Crossing Senior Living |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bloomington<sup>1</sup> | SHO | Mortgage | $2000 | $(800) | $1200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Encore Senior Living | SHO | Construction Loan | 56525 | (41294) | 15231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mainstay Healthcare | SHO | Revolving Credit | 350 | (350) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living | SHO | Revolving Credit | 16500 | (7000) | 9500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living Hospitality Group | SHO | Working Capital | 5000 | (3726) | 1274 |
| &nbsp;&nbsp;&nbsp;&nbsp;The Sanders Trust, LLC | HOSP | Construction Loan | 27720 | (27571) | 149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Timber Ridge OpCo | SHO | Working Capital | 5000 |  | 5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loan commitments |  |  | $113095 | $(80741) | $32354 |

---

<sup>1 &nbsp;&nbsp;&nbsp;&nbsp;</sup>Funding is contingent upon the operating performance of the respective facility.

As of March 31, 2026, the total credit loss liabilities established for our unfunded loan commitments were $0.2 million. We estimate the amounts we expect to fund using the same methodology as the one applied to provide for credit loss reserves on our mortgages and other notes receivable.

A summary of our outstanding development commitments as of March 31, 2026 follows (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Type of<br>Property | Type of<br>Commitment | Total<br>Commitments |<br>Funded |<br>Remaining |
| Bickford | SHO | Renovation | $8000 | $(5293) | $2707 |
| Juniper Communities, LLC | SHO | Renovation | 750 |  | 750 |
| Mainstay Healthcare | SHO | Renovation | 250 | (146) | 104 |
| Senior Living | SHO | Renovation | 10000 | (6889) | 3111 |
| Spring Arbor | SHO | Renovation | 3000 |  | 3000 |
| William James Group, LLC | SHO | Renovation | 600 | (556) | 44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total development commitments |  |  | $22600 | $(12884) | $9716 |

---

A summary of our outstanding contingency commitments as of March 31, 2026 follows (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Type of<br>Contingency | Total<br>Commitments |<br>Funded |<br>Remaining |
| Compass Senior Living | Acquisition consideration | $2750 | $— | $2750 |
| IntegraCare | Lease inducement | 750 |  | 750 |
| Navion Senior Solutions | Lease inducement | 4850 | (2700) | 2150 |
| Spring Arbor | Lease inducement | 10000 |  | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contingency commitments |  | $18350 | $(2700) | $15650 |

---

*Litigation*

From time to time, we are a party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

------

**Non-GAAP Financial Measures**

The supplemental performance measures described below may not be comparable to similarly titled measures used by other REITs. Consequently, our funds from operations ("FFO"), Normalized FFO and Normalized Funds Available for Distribution ("FAD") may not provide a meaningful measure of our performance as compared to that of other REITs. Since other REITs may not use our definition of these performance measures, caution should be exercised when comparing our FFO, Normalized FFO and Normalized FAD to that of other REITs. These performance measures do not represent cash generated from operating activities in accordance with GAAP as they exclude the changes in operating assets and liabilities, and therefore should not be considered an alternative to net income as an indication of our performance or an alternative to net cash flows from operating activities, as determined in accordance with GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs.

*Funds From Operations - FFO*

Our FFO per diluted share for the three months ended March 31, 2026 increased $0.09 per share, or 7.9%, as compared to the three months ended March 31, 2025 primarily due to new investments completed since January 1, 2025, partially offset by dispositions of real estate properties since January 1, 2025. FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT") and applied by us, is calculated using the two-class method with net income allocated to common stockholders and holders of participating securities by applying the respective weighted-average shares outstanding during each period. The calculation of FFO begins with net income attributable to common stockholders (computed in accordance with GAAP) and excludes gains on dispositions of real estate properties, impairments of real estate properties, and real estate depreciation and amortization after adjusting for unconsolidated partnerships and joint ventures, if any. FFO per diluted share attributable to common stockholders assumes the exercise of stock options and other potentially dilutive securities.

Our Normalized FFO per diluted share for the three months ended March 31, 2026 increased $0.08 per share, or 7.0%, as compared to the three months ended March 31, 2025. Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current period to similar prior periods, and may include, but are not limited to including, impairments of non-real estate assets, gains or losses attributable to acquisitions and dispositions of non-real estate assets and liabilities, and recoveries of previous write-downs.

FFO and Normalized FFO are important supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the realizable value of real estate assets diminishes predictably over time. Since real estate asset values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative and should be supplemented with a measure such as FFO. The term FFO was designed by the REIT industry to address this issue.

*Funds Available for Distribution - FAD*

Our Normalized FAD for the three months ended March 31, 2026 increased $6.5 million, or 11.6%, as compared to the three months ended March 31, 2025. In addition to the adjustments made to net income attributable to common stockholders that are included in the calculation of Normalized FFO, Normalized FAD excludes the impact of straight-line rent revenue adjustments, amortization of debt issuance costs and discounts. We also adjust Normalized FAD for the net change in our credit loss reserves, non-cash share-based compensation expense, SHOP capital expenditures, as well as certain non-cash items related to our equity method investment, such as straight-line lease expense and amortization of purchase accounting adjustments. Normalized FAD for the three months ended March 31, 2025 included an adjustment for transaction costs incurred related to a large SHOP transaction that did not materialize. Normalized FAD for the three months ended March 31, 2026 had no equivalent costs.

Normalized FAD is an important supplemental performance measure for a REIT and a useful measure of liquidity as an indicator of our ability to distribute dividends to our stockholders. GAAP requires a lessor to recognize contractual lease payments as income on a straight-line basis over the expected term of the lease. This straight-line rent adjustment has the effect of reporting rental income that is significantly more or less than the contractual cash flows received pursuant to the terms of our lease agreements. GAAP also requires any discount or premium related to indebtedness and debt issuance costs to be amortized as non-cash adjustments to earnings.

------

The following table reconciles our net income attributable to common stockholders, the most directly comparable GAAP financial measure, to NAREIT FFO, Normalized FFO and Normalized FAD and provides supplemental information on basic and diluted earnings per share using these metrics *($ in thousands, except per share amounts)*:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Net income attributable to common stockholders | $40024 | $34113 |
| &nbsp;&nbsp;&nbsp;&nbsp;Elimination of certain non-cash items in net income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate depreciation and amortization | 22832 | 18764 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate depreciation related to noncontrolling interests | (402) | (413) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on dispositions of real estate properties, net | (2612) | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allocations to participating securities | (20) |  |
| NAREIT FFO attributable to common stockholders | 59822 | 52350 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses |  | 264 |
| Normalized FFO attributable to common stockholders | 59822 | 52614 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments | (723) | (1410) |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments related |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to noncontrolling interests | (23) | (12) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | 725 | 725 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives related to noncontrolling interests | (127) | (127) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation | 859 | 393 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation related to noncontrolling interests | (74) | (55) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 644 | 894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discounts | 210 | 80 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments related to equity method investment, net | (399) | (265) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment |  | (415) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment capital expenditures | (76) | (125) |
| &nbsp;&nbsp;&nbsp;&nbsp;SHOP recurring capital expenditures | (719) | (362) |
| &nbsp;&nbsp;&nbsp;&nbsp;SHOP recurring capital expenditures related to |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interests | 39 | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment non-refundable fees received | 127 | 310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit loss (benefit) expense | (50) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash share-based compensation expense | 2240 | 2558 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs |  | 1164 |
| &nbsp;&nbsp;&nbsp;&nbsp;Allocations to participating securities | (4) |  |
| Normalized FAD attributable to common stockholders | $62471 | $56001 |
| Basic: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 48323945 | 45720496 |
| &nbsp;&nbsp;&nbsp;&nbsp;NAREIT FFO attributable to common stockholders per share | $1.24 | $1.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Normalized FFO attributable to common stockholders per share | $1.24 | $1.15 |
| Diluted: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 48547893 | 45878528 |
| &nbsp;&nbsp;&nbsp;&nbsp;NAREIT FFO attributable to common stockholders per share | $1.23 | $1.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Normalized FFO attributable to common stockholders per share | $1.23 | $1.15 |

---

------

*Adjusted EBITDA*

We consider Adjusted EBITDA to be an important supplemental financial measure because it provides information which we use to evaluate our performance and serves as an indication of our ability to service debt. We define Adjusted EBITDA as consolidated earnings before interest, taxes, depreciation and amortization, excluding impairments of real estate properties and gains on dispositions and certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing Adjusted EBITDA for the current period to similar prior periods. These items include, but are not limited to, impairments of non-real estate assets, gains or losses on disposition of assets and liabilities, and recoveries of previous write-downs on mortgages and other notes. Adjusted EBITDA also includes our proportionate share of an unconsolidated equity method investment presented on a similar basis. Since others may not use our definition of Adjusted EBITDA, caution should be exercised when comparing our Adjusted EBITDA to that of other companies. Adjusted EBITDA reflects GAAP interest expense, which excludes amounts capitalized during the period.

The following table reconciles our net income, the most directly comparable GAAP financial measure, to Adjusted EBITDA (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Net income | $39752 | $33817 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 23691 | 19157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 15040 | 14337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 215 | 269 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit loss (benefit) expense | (50) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on dispositions of real estate properties, net | (2612) | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-offs of transaction costs |  | 608 |
| Adjusted EBITDA | $76036 | $68060 |
| Fixed charges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense at contractual rates | $14186 | $13359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments on debt, excluding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;balloon payments |  | 112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fixed charges | $14186 | $13471 |
| Fixed charge coverage ratio | 5.4x | 5.1x |

---

------

*Net Operating Income*

NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate assets. We define NOI as total revenues, less tenant reimbursements and property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of real estate assets at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations to our segments and to assess the property level performance of our investment portfolios.

The following table reconciles our net income, the most directly comparable GAAP financial measure, to NOI (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Net income | $39752 | $33817 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 23691 | 19157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 15040 | 14337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal expense | 305 | 1426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 215 | 269 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 7851 | 6829 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses |  | 264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty gains, net | (50) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on dispositions of real estate properties, net | (2612) | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment |  | (415) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-operating income | (35) |  |
| NOI | $84157 | $75556 |

---

The following table provides a summary of our NOI by segment (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 31, | March 31, |
| | 2026 | 2025 |
| Real Estate Investments segment | $75266 | $72470 |
| SHOP segment | 8891 | 3086 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total NOI | $84157 | $75556 |

---

------

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

*Interest Rate Risk*

We are exposed to risks related to fluctuations in market interest rates that affect our indebtedness and our mortgage and other notes receivable. As of March 31, 2026, we had $434.0 million of principal amounts outstanding on indebtedness and $391.0 million of availability under our Credit Facility that are subject to variable interest rates.

We have historically used derivative financial instruments in the normal course of our business to mitigate interest rate risk. We do not use derivative financial instruments for speculative or trading purposes. We currently have no derivative financial instruments but may engage in hedging strategies to manage our exposure to interest rate risk in the future depending on our analysis of the interest rate environment and the costs and risks of such strategies.

Interest rate fluctuations generally will not affect our future results of operations or cash flows associated with our fixed rate debt, mortgages and other notes unless these financial instruments mature or are otherwise terminated and we are seeking new borrowings or to refinance these borrowings. However, interest rate fluctuations will affect the fair values of our fixed rate financial instruments from period to period. Conversely, changes in interest rates related to our variable rate debt, mortgages and other notes will impact our future results of operations and cash flows, but will not significantly affect the fair values of those financial instruments from period to period. Assuming a 50 basis point ("bps") increase or decrease in the interest rates on the principal amounts outstanding on our variable rate debt as of March 31, 2026 and assuming the amounts outstanding did not change during the period, interest expense would increase or decrease annually by approximately $2.2 million.

The following table provides a summary of the interest rates on our debt (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| | Principal<br>Amounts<br>Outstanding | % of<br>Total<br>Debt |<br>Interest<br>Rate | Principal<br>Amounts<br>Outstanding | % of<br>Total<br>Debt |<br>Interest<br>Rate |
| Fixed rate debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2031 Senior Notes - unsecured | $400000 | 31.2% | 3.00% | $400000 | 33.9% | 3.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;2033 Senior Notes - unsecured | 350000 | 27.3% | 5.35% | 350000 | 29.7% | 5.35% |
| &nbsp;&nbsp;&nbsp;&nbsp;Private placement notes - unsecured | 100000 | 7.8% | 4.51% | 100000 | 8.5% | 4.51% |
| Variable rate debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving credit facility - unsecured | 309000 | 24.0% | 4.73% | 204000 | 17.3% | 4.71% |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank term loan - unsecured | 125000 | 9.7% | 4.93% | 125000 | 10.6% | 4.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total principal amount of debt outstanding | $1284000 | 100.0% | 4.36% | $1179000 | 100.0% | 4.32% |

---

------

The following table provides a summary of the sensitivity of our fixed rate debt as of March 31, 2026 to changes in market interest rates (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | Fair Values | Fair Values |
| | Principal<br>Amounts<br>Outstanding |<br>Fair<br>Values | After 50 bps<br>Decrease | After 50 bps<br>Increase |
| 2031 Senior Notes | $400000 | $349361 | $357197 | $341321 |
| 2033 Senior Notes | 350000 | 347640 | 356873 | 336562 |
| Private placement notes | 100000 | 98687 | 99090 | 98286 |

---

Substantially all of our investments in mortgages and other notes are negotiated at fixed interest rates. As of March 31, 2026, the principal amounts outstanding on these investments totaled $221.3 million and the estimated fair values, discounted for the change in the risk-free interest rate, totaled $203.4 million. A 50 bps increase in market interest rates as of March 31, 2026 would decrease the total estimated fair values of our mortgages and other notes by approximately $8.6 million and a 50 bps decrease in market interest rates would increase the estimated fair values of our mortgages and other notes by approximately $1.7 million.

*Inflation Risk*

Our tenant leases generally provide for annual escalators in contractual rent due to us based on a fixed rate of increase or a variable index, such as the consumer price index ("CPI"). Our tenant leases which are subject to an annual rent escalator based on CPI may also contain a minimum or maximum cap on the annual increase. Substantially all of our leases include a provision that requires the tenant to pay the operating expenses of the respective property, whether paid directly by the tenant or reimbursed to us. We believe that inflationary increases experienced by us will be at least partially offset by the contractual rent increases and operating expense reimbursements described above.

In addition, inflation, both real and anticipated, as well as any resulting government policies have affected, and could continue to adversely affect, the costs of labor, goods and services experienced by our managers in the SHOP segment. In periods of inflation, the increases in operating costs experienced by our operators could exceed the corresponding increases in revenues which may adversely affect our operators' and borrowers' ability to make rent and loan payments to us under the terms of the agreements. Additionally, our financial condition and results of operations may be adversely affected by any shortfall experienced by our operators during periods of inflation.

**Item 4. Controls and Procedures**

*Evaluation of Disclosure Control and Procedures*

As of March 31, 2026, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer ("CEO") and the Chief Financial Officer ("CFO"), of the effectiveness of our disclosure controls and procedures (as defined in rules 13a-15(e) and 15d-15(e) under the Exchange Act) to ensure information required to be disclosed in our filings is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms; and (ii) accumulated and communicated to our management, including our CEO and our CFO, as appropriate, to allow timely decisions regarding required disclosures. Management recognizes that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving desired control objectives, and management is necessarily required to apply its judgment when evaluating the cost-benefit relationship of potential controls and procedures. Based upon the evaluation, the CEO and CFO concluded that the design and operation of these disclosure controls and procedures were effective as of March 31, 2026.

There were no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

*Changes in Internal Control over Financial Reporting*

There were no changes in our internal control over financial reporting identified in management's evaluation during the three months ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

From time to time, we are a party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

**Item 1A. Risk Factors**

There have been no material changes from the risk factors previously disclosed in "Part I, Item 1A, Risk Factors" in our Annual Report, except as noted below.

***Failure to complete the pending sale of the NHC properties could have an adverse effect on our business.***

The consummation of the sale of our entire portfolio of real estate properties leased to NHC is subject to the satisfaction or waiver of a number of conditions, including, but not limited to, the expiration or termination of the applicable waiting period and any extensions thereof under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. There can be no assurance that the conditions to closing will be satisfied or waived in a timely manner or at all. If any of the conditions to closing are not satisfied or waived, the sale may not be consummated or may be delayed. In the event the sale is not completed, we will have incurred significant transaction costs, including legal, accounting and advisory fees, without realizing the anticipated benefits of the sale. A failure to consummate the sale could also result in negative perceptions among tenants, operators, investors and other market participants, which could adversely affect the trading price of our common stock.

***The market price of our common stock may decline as a result of the sale of the NHC properties.***

The announcement and pendency of the sale of the NHC properties may cause disruptions to our business and operations. The sale, if consummated, will result in the disposition of a significant portion of our investment portfolio, which could adversely affect our financial condition, results of operations and ability to make distributions to our stockholders. Moreover, the market price of our common stock may fluctuate significantly in response to market perceptions regarding the sale, including perceptions regarding the likelihood of completion, the terms of the sale and the impact on our business going forward. There can be no assurance that the market price of our common stock will not decline as a result of the announcement, pendency or consummation of the sale.

***We may not be able to successfully redeploy the net proceeds from the sale of the NHC properties in a manner that generates comparable returns.***

Our ability to effectively redeploy the proceeds received in the sale of the NHC properties will depend on a number of factors, including the availability of suitable investment opportunities, prevailing market conditions, competition from other investors and our cost of capital at the time of reinvestment. There can be no assurance that we will be able to identify and acquire assets or make investments that generate returns comparable to the returns generated by the properties being sold, which may impact our results of operations.

**Item 5. Other Information**

None of our directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the three months ended March 31, 2026.

------

**Item 6. Exhibits**

---

| | |
|:---|:---|
| Exhibit |  |
| Number | Description |
| 3.1 | <u>[Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/877860/000087786013000105/exhibit31articlesofincorp.htm)</u> (incorporated by reference to Exhibit 3.1 to Form S-3 Registration Statement No. 333-192322)  |
| 3.2 | <u>[Articles of Amendment to Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/877860/000087786013000105/exhibit32articlesofamendme.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000105/exhibit32articlesofamendme.htm)[dated as of June 8, 1994](https://www.sec.gov/Archives/edgar/data/877860/000087786013000105/exhibit32articlesofamendme.htm)</u>, (incorporated by reference to Exhibit 3.2 to Form S-3 Registration Statement No. 333-194653) |
| 3.3 | <u>[Amendment to Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)[, dated May 1, 2009](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)</u> (incorporated by reference to Exhibit A to the Company's Definitive Proxy Statement filed March 23, 2009) |
| 3.4 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 2, 2014](https://www.sec.gov/Archives/edgar/data/877860/000087786014000058/nhi-6302014x10qex33.htm)</u> (incorporated by reference to Exhibit 3.3 to the Form 10-Q filed August 4, 2014) |
| 3.5 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 6, 2020](https://www.sec.gov/Archives/edgar/data/877860/000087786020000091/amendmenttoarticlesofi.htm)</u> (incorporated by reference to Exhibit 3.6 to the Form 10-Q filed August 10, 2020) |
| 3.6 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 21, 2025](https://www.sec.gov/Archives/edgar/data/877860/000087786025000135/nhi-6302025xex36nhiamendme.htm)</u> (incorporated by reference to Exhibit 3.6 to the Form 10-Q filed August 6, 2025) |
| 3.7 | <u>[Amended and Restated Bylaws as approved February 17, 2023, as amended April 27, 2023](https://www.sec.gov/Archives/edgar/data/877860/000087786023000066/nhiamendedandrestatedbylaws.htm)</u> (incorporated by reference to Exhibit 3.5 to the Form 10-Q filed May 9, 2023) |
| 10.1 | <u>[P](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[urchase and Sale](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[Agreement, dated as of April 2](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[1](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[, 2026](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[by and among National Health I](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[nvestors, Inc. and NHC/OP, L.P. and cer](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[tain of their](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[respective affiliates named t](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)[herein](https://www.sec.gov/Archives/edgar/data/877860/000087786026000117/ex101psadated4-21x2026amen.htm)</u> (incorporated by reference to Exhibit 10.1 to the Form 8-K/A filed April 22, 2026) |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex311q1202610-q.htm)</u> (filed herewith) |
| 31.2 | <u>[Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex312q1202610-q.htm)</u> (filed herewith) |
| 32 | <u>[Certification of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32q1202610-q.htm)</u> (filed herewith) |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | <u>NATIONAL HEALTH INVESTORS, INC.</u> |
| | | (Registrant) |
| Date: | May 4, 2026 | /s/ D. Eric Mendelsohn |
|  |  | D. Eric Mendelsohn |
|  |  | President, Chief Executive Officer and Director |
|  |  | (Principal Executive Officer and Duly Authorized Officer) |
| Date: | May 4, 2026 | /s/ John L. Spaid |
|  |  | John L. Spaid |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1** 

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, D. Eric Mendelsohn, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of the registrant, National Health Investors, Inc., for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 4, 2026 | /s/ D. Eric Mendelsohn | /s/ D. Eric Mendelsohn |
| | | Name: | D. Eric Mendelsohn |
| | | Title: | President, Chief Executive Officer and Director |
| | | | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2** 

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, John L. Spaid, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of the registrant, National Health Investors, Inc., for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 4, 2026 | /s/ John L. Spaid | /s/ John L. Spaid |
| | | Name: | John L. Spaid |
| | | Title: | Chief Financial Officer |
| | | | (Principal Financial Officer) |

---

## Ex-32

**Exhibit 32**

**CERTIFICATION** 

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that, to the undersigned's best knowledge and belief, the following related to the quarterly report on Form 10-Q for National Health Investors, Inc. ("Issuer") for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 4, 2026 | /s/ D. Eric Mendelsohn | /s/ D. Eric Mendelsohn |
|  |  | Name: | D. Eric Mendelsohn |
|  |  | Title: | President, Chief Executive Officer and Director |
|  |  |  | (Principal Executive Officer) |
| Date: | May 4, 2026 | /s/ John L. Spaid | /s/ John L. Spaid |
|  |  | Name: | John L. Spaid |
|  |  | Title: | Chief Financial Officer |
|  |  |  | (Principal Financial Officer) |

---

<br>